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ABSTRACT
Strains of Legionella pneumophila which were virulent for guinea pigs
were passaged on laboratory media such that they became avirulent.
Virulent/avirulent pairs of strains were compared in an attempt to identify
potential virulence or pathogenic factors.
Virulent forms multiplied within guinea pig alveolar macrophages
maintained in tissue culture over 48 hours and phagosome lysosome fusion
was not inhibited in these macrophages. Avirulent strains did not multiply
but those produced by passage on supplemented Mueller Hinton agar
(MHIH) maintained viability whereas those produced by passage on
buffered charcoal yeast extract agar (BCYE) were killed. Virulent
legionellae produced more flagella than their paired avirulent forms but it
was considered unlikely that this was related to pulmonary virulence.
Minor differences in outer membrane proteins and reactivity with various
antisera were observed between virulent/avirulent pairs but these were not
consistent between the L.pneumophila strains and no virulence-associated
proteins were found. The lipopolysaccharide and extracellular enzyme
activities of the pairs of strains were indistinguishable.
The Corby strain of L.pneumophila (CV) was isolated from its intracellular
in vivo environment and these bacteria compared with the same strain
grown on BCYE. The in vivo-grown CV showed no change in uptake by,
or intracellular replication within, alveolar macrophages but, when Western
blotted and incubated with various antisera, the two types of bacteria
reacted differently. There was a reduced reaction by the CV grown in vivo,
suggesting a change in the number and/or type of proteins expressed when
exposed to an intracellular environment. The cellular responses in the lungs
of guinea pigs immediately following aerosol challenge with virulent and
avirulent forms of the Corby strain were compared. The avirulent forms
evoked little change in the alveolar cell populations whereas an
inflammatory response to CV occurred. Polymorphonuclear Ieucocytes
(PMNLs) were the principal cell type involved and the initial increase in
numbers of this cell type corresponded with a transient decrease in the
viablility of CV, providing evidence that virulent L.pneumophila are killed
by PMNLs. The multiplication of CV which followed suggested a
developing resistance to the killing. Numbers of avirulent Corby decreased
rapidly and, for the MHIH passaged form (CA), this was in contrast to its
intracellular survival in vitro. An attempt was made to follow the changes
in cellular responses using immunolabelling techniques and flow
cytometry. Difficulties with obtaining consistent, sequential samples did
not allow a full interpretation of the results but the technique showed
promise for such studies.
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The tissue destructive protease (TDP) of L.pneumophila was shown to
degrade or inactivate gamma interferon, IgG and possibly interleukin 2,
proteins of possible significance to the host in protection against infection
with L.pneumophila. Inhibition of TDP by the protease inhibitor a2
macroglobulin was demonstrated and, prophylactic treatment of guinea
pigs with the inhibitor resulted in prolonged survival (compared with
untreated controls) following aerosol challenge with CV. Intracellular
production of TDP by L.pneumophila multiplying within guinea pig
alveolar macrophages was demonstrated by ELISA and immunogold
labelling and functional activity of the enzyme purified from infected
guinea pig lungs was shown. A mutant of L.pneumophila, deficient in TDP
production, was compared in the guinea pig model with its TDP-producing
parent and CV. The mutant and parent were considerably less virulent than
CV but, despite the deficiency in TDP production, the mutant was lethal
for guinea pigs. The lung damage caused by the mutant was less severe
than that caused by the parent or CV and it was suggested that progression
of disease and cause of death was not typical of Legionnaires' disease.
An immunocompromised mouse model of Legionnaires' disease was
investigated using aerosol infection of severe combined immune deficient
(SeID) mice. SCID mice did not become ill when given a potentially lethal
aerosol of L.pneumophila and alveolar macrophages of these mice did not
support the growth of L.pneumophila in vitro. SCID mice which had been
reconstituted with human leukocytes were susceptible to aerosol challenge
and developed lung lesions similar to those seen in guinea pigs and
humans.
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CHAPTER 1
General Introduction to Legionnaires' disease and Legionella
pneumophila
1.1 mSTORICAL BACKGROUND
Legionnaires' disease (LD) is an acute bronchopneumonia caused by
certain members of the Legionella genus but most commonly by
L.pneumophila. First identification of the causative agent occurred in the
fairly recent past in 1976 following an outbreak of bronchopneumonia at
the Legionnaires' conference in Philadelphia (Fraser et aI, 1977). Since
then retrospective serology showed that LD was not a new disease and that
many past deaths due to pneumonia of unknown aetiology were in fact a
result of LD (Thacker et aI, 1978, CDC, 1977). Once a suitable culture
medium had been found ( McDade et aI, 1977) more cases of LD were
discovered and it soon became apparent that L.pneumophila was a cause
of both community acquired and nosocomial pneumonia (Broome et aI,
1979). A pattern of patient susceptibility emerged with the main risk
groups being the elderly and immunocompromised individuals.
Not long after the discovery that L.pneumophila causes LD the same
organism was shown to be responsible for an outbreak of a flu-like
illness that had a similar aetiology to LD with its dissemination from
environment to patient but the resulting disease was quite different. The
condition termed Pontiac Fever after the site of the first recorded outbreak
(CDC, 1968, Glick et aI, 1978), is a milder, non-invasive, non-
pneumonic, febrile disease with many poorly defined symptoms that make
epidemiological studies difficult (Glick et 01, 1978). The disease is
characterised by a much higher attack rate than LD and is not restricted
to certain population groups. It is 'not known why the same organism
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causes two distinct diseases. It is unlikely to be simply a milder form of
the same disease because cases of Pontiac fever are not associated with LD
outbreaks and vice versa (O'Mahonyet ai, 1990, Goldberg et al., 1989).
The Philadelphia 1 strain of L.pneumophila which caused the original
outbreak was designated serogroup 1 as strains, which were later
isolated from water systems and patients, did not cross react with sera
raised against this first isolate. To date 14 serogroups of
L.pneumophila have been identified but serogroup 1 is by far the most
common cause of Legionellosiswith 50% of cases due to serogroup 1 and
10% to serogroup 6 (Reingold et ai, 1984). Other Legionella species are
known to cause LD and Pontiac Fever. Several of these are regular disease
producers e.g. Lmicdadet, Lbozemanii, but many have been identified
as a result of being responsible for isolated outbreaks or cases e.g.
L.longbeachae (Steele et al, 1990), Lsainthelensts (Garcia et al, 1992).
Recent data showed that of the 32 Legionella species only half have
been reported as pathogenic for humans, the rest being isolated from
environmental sources (Benson et ai, 1991). However, a survey of
potable water systems in the U.K. (Dennis et ai, 1982) revealed that
legionellae that were not associated with human disease were nonetheless
virulent for guinea pigs indicating that a potential source of legionellosis
exists wherever legionellaeare found.
The bacterium's natural habitats are water and soil and virtually any means
by which aerosolisation of such habitats can happen have lead to the
occurrence of LD~ The most common sources of infectious aerosols are
man-made water systems particularly cooling towers, hot water systems,
humidifiers and whirlpoolbaths (Breiman, 1993).
Extensive surveys carried out in several countries revealed that the
bacteria could successfully colonise man-made water systems even if
these were well maintained (many were not). It was clear that
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legionellosis had to be considered in the construction and maintenance
of such systems. Guidelines and Codes of Practice have now been
produced (HSE, 1991) which should decrease the incidence of LD
considerably. However, as one source of infection is being tackled
others are coming to light. The recent popularity of whirlpool baths for
example has lead to many cases ofLD and Pontiac Fever.
The incidence of Legionellosis in England and Wales appears to be
falling, possibly as a result of more public awareness and the damaging
consequences to employers and governmentof preventable outbreaks. The
problem is larger in the USA where an estimated incidence of
pneumonia due to legionellae is 1120,000 people annually (Marston et
ai, 1993). Fortunately, large outbreaks are becoming less frequent but
community acquired pneumonia continues to be a problem. Sporadic cases
of LD are difficult to evaluate epidemiologically and, although many are
travel-associated, the danger that a sporadic case may be the start of an
outbreak means that despite falling numbers of cases it is vital to
maintain public awareness and vigilance for a potentially dangerous
disease.
1.2. CLINICAL FINDINGS, DIAGNOSIS AND TREATMENT.
Legionnaires' disease is often described as an atypical pneumonia but this
is possibly a misnomer since there are few clinical features that clearly
distinguish LD from other pneumonias or indeed conditions other than
pneumonia. The early symptoms of infection are similar to those of
influenza, i.e. headache, fever, chills and muscle pain. The illness that
follows often exhibits extra-pulmonary symptoms involving the
gastrointestinal tract, central nervous system and kidneys. During an
outbreak such as that which occurred at the BBC where individuals
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dispersed from the source of infection, the non-specific nature of
symptoms is a problem, particularly in the early stages of infection.
The yardstick of diagnosis of LD is demonstration of the bacterium in
lung tissue either by culture or by immunostaining. Culture is the most
sensitive method, in that one viable bacterial cell can be detected but
this level of sensitivity is dependent on the culture medium and
difficulties with quality control of media, particularly between
laboratories, creates a problem. These difficulties are being recognised
and better standardised media are being sought. A major problem with
culture methods is the danger that the portion of respiratory" tract being
cultured does not contain any organisms since the infection can be
very localised. Increasingly there are cases of LD caused by strains that
are not culturable on laboratory media (Hussong et aI, 1987) but which
will multiply in protozoa (Rowbotham, 1993). These so called
Legionella-like amoebal pathogens (LLAPs) have now been confirmed
as belonging to the Legionella genus by 16S ribosomal RNA typing (
Rowbotham, 1993). Thus, perhaps culture methods should include
incubation of specimens with amoebae. Demonstration of Legionella
antigens m lung tissue (obtained by biopsy) by immunochemical
techniques is a very specific test and does not require viability of the
bacteria. It has proved useful in environmental sampling but has a low
sensitivity in that several bacteria need to be present for a confirmatory
result.
The most recent ; development in diagnosis of LD is detection of
Legionella DNA by polymerase chain reaction (PCR). This method
requires only one bacterium to be present in the sample and is
potentially as sensitive or more sensitive than culture methods but given
the above mentioned difficulties with culture, PCR would seem more
promising. As yet sensitivities equivalent with culture are not being
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achieved (Tompkins, 1993) and specificity is also a problem but as
applications of this technique are expanding it is likely to improve and
become more widely used to detect legionellae.
Direct demonstration of identifiable legionellae m respiratory
specimens is the ideal diagnosis when possible but often the disease can
only be diagnosed by demonstration of specific antibody in patients'
sera. An indirect immunofluorescence antibody test (IFAT) is used and a
four-fold rise in antibody titre (over 3-6 weeks) or a single high titre is
required as positive diagnosis. Production of high levels of antibody can
take time especially in an immunocompromised patient. This delay could
be a serious problem for a patient requiring urgent specific treatment.
Another problem with serology is that of cross reactions. Patients can
develop antibodies that cross react with antigens of other pathogens (e.g.
Rickettsia, Mycobacteria, Bacteroides and Pseudomonas species) or
species and serogroups of Legionella other than that causing disease.
The problem appears to be worse when disease is due to strains other
than L.pneumophila serogroup 1. This may be a reflection of the antigens
used to perform the serology since they are better characterised for
serogroup 1. The main problem with serology is that methods are not
standardised and different laboratories use a variety of antigen
preparations and control sera. Improvements in methodology and
adoption of standard procedures will enhance the usefulness of serology
but the delay factor of antibody development will always be a
drawback to the diagnosis ofLD by this technique.
A diagnostic technique that has been studied for many years IS
detection of specific antigen in non-pulmonary body fluids the most
convenient of these being urine (Berdal et ai, 1979, Tilton, 1979,
Mangiafico et ai, 1981). Antigen appears in urine early on in the
disease long before antibody production (Williams & Featherstone, 1988)
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and in quantities sufficient to be reliably detected by sensitive,
quantitative techniques such as radioimmunoassay (RIA, Kohler, 1981)
and enzyme linked immunosorbent assay (ELISA, Berdal et ai, 1979,
Williams & Featherstone, 1988). Several kits for urinary antigen detection
are available but have not yet become part of the standard procedures in
hospitals. This is partly due to poor performance of latex agglutination
assays having low sensitivity and specificity (Leland and Kohler, 1990)
and reluctance to use RIA methods. However ELISA kits have given very
promising results in several laboratories and should provide a diagnostic
test of the future particularly where the assay has been improved to detect
antigens from serogroups and species other than L.pneumophila
serogroup 1 (Tang & Krishnan, 1993, Williams and Lever, unpublished).
Early identification of a case of LD is vital to curtail outbreaks but it is
more important to administer the most effective antibiotic therapy.
Legionellae are intracellular pathogens so the antibiotic used must be
bactericidal and be able to penetrate the alveolar macrophages in which
the bacteria multiply (Winn et ai, 1978). The first antibiotic used to treat
the disease was Erythromycin (Kirby et ai, 1980) and is still in use today
although there is some doubt about its efficacy both in patients (Miller,
1981) and in experimental animals (Fitzgeorge, 1985, Fitzgeorge et ai,
1986). Erythromycin is less able to prevent intracellular growth of
L.pneumophila than other antibiotics such as Rifampicin and
Ciprofloxacin which successfully arrest the progress of acute
experimental airborne LD (Fitzgeorge et ai, 1986).
Prevention of LD is a multi-component problem. Ideally, the source of
infection should be eradicated, which means prevention of
legionellae colonising any water system from which aerosols can be
produced. Since such systems include domestic water supplies where
taps and shower heads provide the aerosol it would seem an enormous
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task to undertake. Clearly in public buildings, especially hospitals,
there is no question that all steps must be taken to prevent colonisationbut
as more is discovered about this organism in the environment the more
extensive the procedures become. With the increased incidence of
sporadic LD where each case can be due to a different set of
circumstances, control of disease rests more heavily on rapid diagnosis
and effective treatment.
1.3. LEGIONELLA PNEUMOPHILA
Classification of the Legionella genus has become extremely
complicated over the years and strains can now be classified by
serology, ribotyping (Saunders et al., 1988, Grimont et al., 1989),
plasmid type (Stout et al., 1988), restriction fragment length
polymorphism (RFLP, Saunders et al., 1990) electrophoretic alloenzyme
typing (Selander et al, 1985, Tompkins et al., 1987), quinone analysis
(Karr et al., 1982, Wait, 1988) together with other techniques. Serology is
the most commonly recognised basis for categorisation of legionellae
but the increasing number of monoclonal antibody panels which
distinguish sub-groups of L.pneumophila serogroup 1 has led to a very
complicated system of typing. The confusion created by the different
antibody types led to developmentof alternative methods of classification.
Techniques such as electrophoretic alloenzyme typing and quinone types
have separated the strains which overlap by serology but are not
methods easily adopted by many laboratories. A successful typing
technique is RFLP which distinguishes strains by DNA fragment patterns
following restriction enzyme digestion and is a means of clearly
matching clinical with environmental strains (Saunders et al, 1990).
Serology remains the widely used technique which will undoubtedly
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change as monoclonal antibody stocks run down and more laboratories
adopt genetic methods for diagnosis and epidemiology.
1.4. ECOLOGY
L.pneumophila is a fastidious organism that utilises amino acids as its
carbon source having a particular requirement for iron and cysteine.
Legionellae have been found in a wide variety of natural water habitats
(Lee and West, 1991) including lakes, rivers, estuarine and marine waters
and in pockets of water on plants in rain forests. They are also found in
moist soil. A preference for wanner water (between 20-400C, Dennis et
al., 1984, Wadowsky et al., 1985) is the reason there is a greater
number found in man-made water systems. In a number of these water
environments nutrients are scarce and the legionellae have to occupy a
particular ecological niche to survive. In recent years much attention has
focused on the ability of legionellae to survive and multiply in single celled
protozoa such as amoebae. It was originally reported by Rowbotham
(1980) that legionellae could be found in the trophozoites and within
cysts providing protection from adverse environmental conditions. A
number of amoebal species can be infected as well as species of
Tetrahymena. Rapid multiplication of legionellae has been observed and
so amoebae and related organisms provide not only protection but also
may provide a reservoir for its maintenance in aquatic habitats
Another niche for legioneUae in the environment is in biofilms which are
crusts of micro-organisms which colonise surfaces in natural or man
made water systems. The diversity of organisms in a biofilm means that
by-products of one organism may be raw materials for another for
example, Cyanobacteria and green algae have been shown to support the
growth of L.pneumophila in basal culture media (Tison et al., 1980,
Hume & Hann, 1984). Bacteria such as Flavobacterium and
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Pseudomonas spp. can similarly promote growth of L.pneumophila
though this has not been proven to occur in the environment(Lee and
West, 1991). However, Lee and West, (1991) found that when the
micro flora from a water sample containingL.pneumophila was inoculated
into sterilised tap water in a chemostat model, the legionellae
persisted in mixed culture for over two years. Biofilms can also provide
protection for legionellae fromwater currents and biocides.
1.5. VIRULENCEAND PATHOGENESIS
L.pneumophila is a recently discovered pathogen but ··due to the
severity of the disease and the large outbreaks which have occurred, a
great deal of research effort has been devoted to elucidating the
virulence and pathogenesis of the organism. A brief overview is given here
sincemany of the topics are covered in the Chapters that follow.
L.pneumophila is an intracellular pathogen and is now known to be able
to replicate in many cell types at least in vitro (Cianciotto et ai, 1989b).
If phagocytosis of L.pneumophila is prevented no replication takes place
in vitro (Elliott and Winn, 1986). Outer membrane proteins of the
organism have been widely studied and candidates for the mediators of
attachment uptake and intracellular protection have been proposed. Many
proteins have yet to be allocated a role. Excreted proteins, in particular
enzymes, have been discovered which are toxic to the host and can modify
host defence mechanismsbut the absolute dependence on the production of
these for virulence has not been shown.
In lungs,' L.pneumophila multiplies within alveolar macrophages and
much of the recent research is based on the possible mechanismsby which
the bacterium resists the anti-microbial defences of this cell. Evidence of
resistance to the respiratory burst of macrophages has been found but as
yet it has only been demonstrated in in vitro experiments. The discovery
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that L.pneumophila Philadelphia 1 strain inhibited the fusion of lysosomes
with phagosomes containing the bacteria has been previously accepted as
true for all virulent legionellae(Horwitz, 1983a, Dowling, et al., 1992). As
more and more strains are being studied differences between these and
the Philadelphia I strain are emergingand not all strains appear to inhibit
phagosome-lysosome fusion (Rechnitzer and Blom, 1989). This implies
that such strains must be resistant to the lysosomal contents but due to the
wide acceptance of phagosome lysosome fusion inhibition an alternative
mechanism of resistance has not so far been reported.
Virulence factors without which the organism is unable to cause disease
have yet to be clearly identified for L.pneumophila and in a recent review
it was proposed that the reason is because there is no single factor
(Engleberg, 1993). Avirulent forms of L.pneumophila have been
extensively studied in order to identify such a factor and mutants lacking a
particular factor have been reported to have reduced virulence. Examples
of these modified bacteria are described in the followingChapters.
1.6. ENVIRONMENTALFACTORS IN VIRULENCE
It is well established that the source of infectious legionellae is water but
that the mere presence of the bacteria is not necessarily a precursor to
disease. In order to cause disease the organism must not only have the
inherent ability to invade and escape host defences but must exhibit
equally important environmental virulence factors. These are principally
the ability to survive and multiply in the environment (i.e. the source of
infection) and to survive conditions on the route to the host. Most
frequently the dissemination is by aerosolisation and parameters which
affect the survival of legionellae within aerosol particles are critical in
determining whether infection occurs. The size of the aerosol particles is
also critical since these must be small enough (3.5J.1min diameter) to reach
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the lower respiratory tract. Larger particles containing virulent
L.pneumophila, administered intra-nasally, do not produce Legionnaires'
disease (Fitzgeorge et al., 1983). The fact that a relatively small
proportion of all the Legionella species and sub-species which have
been isolated are associated with human disease is probably a
reflection of the conditions in the environment rather than inherent
virulence of the bacteria. A number of environmental factors have been
shown to affect the potential to cause disease including temperature of
the water (Dennis et aI, 1984 Mauchline et al., 1992 & 1994), the ability
of the organism to survive in aerosols which depends on the relative
humidity of the air (Berendt, 1980 ,Hambleton et 01, 1983,) and
physical characteristics of the bacteria such as growth phase
(Hambleton et 01, 1983) and surface hydrophobicity (Dennis, 1986,
Dennis and Lee, 1988). An interesting feature of LD is that a particular
strain or species will continue to cause outbreaks or sporadic cases in a
particular geographical area, be that a building, a town, or a country but
that strain rarely causes disease elsewhere. Such a strain is able to
exploit a particular niche but its ability to be pathogenic is restricted to
that set of circumstances. This epitomises the opportunistic nature of this
genus which makes LD so difficult to predict and control.
1.7. RESISTANCE OF HOST TO LD
Cell-mediated immunity is reported to play an important role in
defence against LD (Horwitz, 1983b, Friedman, 1988). Much of the
evidence for this is based on in vitro studies or on the responses of guinea
pigs to sub lethal infections. Avirulent L.pneumophila strains have been
reported to induce cellular immunity in guinea pigs following aerosol
challenge (Blander, 1989).
11
Much information is available about mechanisms by which the host may
prevent uptake and replication of Lpneumophila mostly requiring
activation or up-regulation of macrophage function. In vitro studies have
shown a number of ways of stimulating this cell to inhibit intracellular
growth including non-specific activation by LPS (Egawa et ai, 1992) and
by T-cell derived factors (Nash et ai, 1984, Nikaido et ai, 1989,
Yamamoto et ai, 1992) in particular gamma interferon (IFNy) (Nash et al
1988, Jensen et al 1987). Vaccination of guinea pigs with L.pneumophila
and its growth products has been shown to induce cell-mediated protection
against aerosol challenge and non-specific stimulation of cellular immunity
is also protective (Gibson et ai, 1985, Yoshida et ai, 1987). However there
is no evidence that macrophage activation occurs in humans or
experimental animals which have not been pre-treated or immunised.
The aim of the studies reported in this thesis was to contribute to the
understanding of the virulence and pathogenesis of LD by investigation of
the interaction of virulent and avirulent strains of L.pneumophila with a
guinea pig host using a model of infection which delivered the organisms to
the animals as a fine particle aerosol. Chapter 2 is an investigation of the
strains in vitro with reference to possible virulence and pathogenic
factors. Studies of the behaviour of the strains in vivo and the host
response following airborne challenge are described in Chapter 3.
Previous studies by the author into the role of L.pneumophila protease in
pathogenesis were extended in the light of reports that the enzyme was not
required for virulence, the results are given in Chapter 4. The final chapter
investigates a novel animal model of LD and describes the behaviour of
a virulent strain in immunocompromised mice.
12
pathogenic factor or mechanism is one which facilitates or aids
progression or severity of infection but is not necessarily an absolute
requirement to cause disease. A virulence factor is one without which
the bacterium would not cause disease.
13
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CHAPTER2
A comparison of virulent and avirulent forms of L.pneumophila
2.1. INTRODUCTION
When Legione/la pneumophila was identified as the causative
organism of Legionnaires' Disease (LD) one of the first culture media
found to support its growth was Mueller Hinton agar supplemented with
haemoglobin and isovitalex (MHlli) (Feeley et al. 1978). It was later
discovered that strains recovered from MHlli were avirulent and several
workers have reported this conversion as evaluated in various animal and
in vitro models of LD virulence. McDade and Shepard (1979)
reported that the Philadelphia 2 strain of L.pneumophila which had
been passaged for 6 months on MlllH was less virulent in embryonated
eggs than the same strain propagated through either guinea pigs or yolk
sacs and the MHIH passaged strain was completely avirulent for guinea
pigs when administered intra-peritoneally (i.p.). Organisms passaged
through guinea pigs did not grow on MlllH agar. Wong et al. (1981)
compared a clinical isolate of L.pneumophila which had lost its' virulence
for guinea pigs following culture on MlllH agar with a different strain
which had been maintained in embryonated eggs. After 3 passages m
cultured human lung fibroblasts the media-attenuated strain reverted to a
virulence equivalent to the egg-grown strain. Elliot and Johnson (1982)
also demonstrated avirulent to virulent conversion of MHIH grown
bacteria following repeated passage through guinea pigs and, to a
lesser extent, through embryonated eggs. Catrenich and Johnson (1988)
have since reported that this reversion to virulence did not occur if the
culture was passaged 25 times on MHIH or if a single colony growing on
MHIH was tested. This suggests that the virulence switch is irreversible
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and in the previous studies, passage of avirulent suspensions through
gumea pigs or eggs resulted in selection and enrichment of a few
remaining virulent cells within the cultures. A study by Horwitz (1987)
showed that passage on MHIH of the Philadelphia 1 strain of
L.pneumophila resulted in forms which were avirulent in guinea pigs and
were also unable to multiply in cultured human monocytes due to an
inability to inhibit phagosome lysosome fusion. When the outer
membrane proteins, extracellular enzymes and serum resistance of the
avirulent bacteria were compared with the virulent parent strains there
were no differences which would account for the virulence switch.
Repeated subculture on buffered charcoal yeast extract (SeYE) agar
can also convert strains to avirulence (Jepras et al., 1985). Despite the
availability of such avirulent forms of L.pneumophila, the molecular
mechanisms which account for the change in virulence are largely
unknown.
Avirulent forms of pathogens provide useful tools for elucidating the
pathogenic mechanisms of the virulent organism but it is vital, when
companng virulent with avirulent organisms, that the method of
characterisation of virulence is relevant to the natural disease. Many of the
studies of avirulent forms of L.pneumophila have involved models of
disease which do not follow the usual route of infection. All used
i.p. administration of the organism into guinea pigs or inoculation of hens
eggs (Elliot & Johnson, 1982). An aerosol infection guinea pig model of
LD developed by, Baskerville et al (1981) has been well established as
closely resembling the disease in humans. The use of such a model
allows virulence of strains to be compared reliably using the natural route
of acquisition/infection. The mechanisms by which the virulent strains
evade host defences and why the avirulent strains are susceptible, can also
be investigated. Since the alveolarmacrophage is the primary component
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of the host with which L.pneumophila interacts, guinea pig alveolar
macrophages obtained by lung lavage provide a means of studying the
interaction of these cells with various strains more closely in vitro.
Avirulent forms of bacterial pathogens often lack a vital virulence factor
without which disease cannot be established. Such virulence factors
include toxins, enzymes, lipopolysaccharide (LPS), outer membrane
proteins, flagella and pili.
The aim of the following study was to examine attenuated forms of
clinical isolates of L.pneumophila which had been passaged on MHlli
and BCYE agars and compare them with each other and with the original
strain in terms of virulence for guinea pigs and infectivity for guinea pig
alveolar macrophages and expression of factors likely to be involved in
virulence and pathogenesis. The results of these comparisons will be
discussed with reference to putative pathogenic mechanisms which have
been suggested for L.pneumophila.
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2.2. MATERIALS AND METHODS
2.2.1. ORGANISMS
Human isolate strains of Legionella pneumophila serogroup 1 were
originally isolated on BCYE and stored at -70oC. The strains used were all
clinical isolates from patients with Legionnaires' disease. The Corby strain
was kindly provided by Dr.R.A.Swann (John Radcliffe hospital, Oxford,
U.K.), Stafford was the strain which caused an outbreak at Stafford
General Hospital and Dodge was isolated from a patient at the PHLS
laboratory, Portsmouth.
Passage of these strains on laboratory media is depicted in Fig.2.1
2.2.2. MEDIA
Bacterial culture media used in the study were: buffered charcoal yeast
extract agar (BCYE, Edelstein, 1981); Mueller Hinton supplemented with
haemoglobin and "Vitox" (Oxoid, SR90) (MHIH, Feeley et al., 1978);
yeast extract broth (YEB, Ristroph, 1980). Tissue culture medium was
modified Eagles medium (MEM, Imperial Laboratories) supplemented
with 0.075 % sodium bicarbonate and 201nM HEPES buffer.
2.2.3. ANIMAL MODEL
The aerosol infection guinea pig model used in the characterisation of
virulence of strains was that described by Baskerville et al. (1981).
Female guinea pigs were exposed to an aerosol < 5J.ll1lin diameter,
generated from water suspensions of L.pneumophila with a 3-jet Collison
spray by means of a Henderson apparatus. Viable counts were
performed on macerated lungs taken immediately after spraying
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Fig.2.I. Passage of L.pneumophila strains on BCYE and MHlli agars in
order to derive avirulent forms,
19
(0 hours) to determine the numbers of legionellae retained in the lungs.
The animals were observed for signs of illness e.g. weight loss and
increased temperature, and deaths were recorded. The viable counts at 0
hours and subsequent animal deaths were used to calculate LDso's by the
Reed and Muench method (Reed and Muench, 1938).
Multiplication of the legionellae following aerosol challenge was monitored
by viable counts on macerated lungs taken from individuals in a group of
guinea pigs at intervals post infection.
2.2.4 GUINEA PIG ALVEOLAR MACROPHAGES
Lungs of normal, guinea pigs were washed out post-mortem m
tissue culture medium (MEM) containing 5Uheparin ml-l and 20 mM L-
glutamine using a procedure described by Jepras et al. (1985). Cells were
harvested from the lavage by centrifugation at 200g for 10 min and
resuspended in MEM containing 5% autologous guinea pig serum
(MEMb). Cells were counted in a Neubauer haemocytometer
chamber, adjusted to 1 x 105-106 macrophages /ml and 200J,Jl aliquots
added to wells of a 96 well tissue culture plate (Nunc) and allowed to
settle at 370C for 30 min. Non-adherent cells were then washed away
withMEMb.
2.2.5. INFECTION OF GUINEA PIG ALVEOLAR MACROPHAGES
Bacterial suspensions were quantified by viable count on BCYE,
suspended in MEMb and added to macrophages at a concentration which
yielded 100 organisms/macrophage. A 2 hour period of incubation at
370C was allowed for ingestion of organisms after which extracellular
bacteria were killed by incubating for 2 hours with 50 ug/ml
gentamicin in MEMb followed by 3 washes with MEMb, a procedure
which does not kill intracellular L.pneumophila (Fitzgeorge, 1985). To
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count intracellular bacteria the macrophages were disrupted by adding
200 J.110.8% (w/v) digitonin in sterile distilled water to each well and
incubating for 10 mins at 370C. This detergent has been shown previously
to have no effect on the viability of L.pneumophila (Fitzgeorge, 1985). The
contents of each well were aspirated and added to 1.8 ml of distilled
water. This suspension diluted further as necessary was plated onto
BCYE agar. Extracellular organisms were enumerated by plating out serial
dilutions of culture supernatants. Intracellular growth of organisms was
investigated by incubating infected macrophages at 370C for 24 and 48
hours followed by washing the macrophage culture with MEMb and then
disruption by digitonin treatment and enumeration of bacteria by viable
counts. Colonies were counted after 3 days incubation at 370C in all cases.
Controls were included to determine the effects of digitonin and MEMb
on the growth of bacteria. During the course of infection macrophages
were examined under phase contrast microscopy. To compare uptake of
the strains by macrophages the bacterial suspensions were incubated with
the cell sheet for 20, 40, 60, 80 100 and 120 min and intracellular counts
performed as above.
2.2.6. GROWTH OF STRAINS IN GUINEA PIG LUNG LAVAGE
The lungs of normal and L.pneumophila infected guinea pigs were
washed out with O.12M potassium chloride (since sodium chloride has
been shown to be inhibitory to L.pneumophila, Feeley et al., 1979) and
centrifuged to remove all cells. Lavages from infected animals were
filtered through a 0.22J.1ffi diameter filter (Amicon) to remove all the
organisms. A concentrate was produced by using a lavage fluid which had
been taken from one guinea pig to successively wash out the lungs of 4
more guinea pigs. Lavage fluid was added to the wells of a 24 well tissue
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culture plate (Nunc) and known concentrations of the various strains
added. Viable counts of the wells were performed at 0, 24 and 48h.
2.2.7. PHAGOSOME LYSOSOME FUSION
Guinea pig macrophages washed out of normal gumea pig lungs were
counted and characterised and adjusted to a concentration of
approximately 1 x 106 cells Iml in MEMb. Aliquots of 0.5 ml were
incubated with lysosome markers at 370C in siliconised glass tubes (to
prevent macrophages adhering) for various lengths of time to determine
an optimum uptake period. The lysosome markers used were, thorium
dioxide (Thoria sol, Polysciences) and colloidal gold (1 nm particle size)
stabilised with bovine serum albumin (BioCell). Excess marker was
washed off and the cells incubated for a further 3 hours to allow all the
marker to be internalised. Bacterial suspensions were added as above
and the cells incubated for 6 and 20 hours. Incubation was stopped by
placing the cells in ice. The cells were fixed in 2.5% glutaraldehyde for 2-4
hours at 4oC, post-fixed in osmium tetroxide then pelleted in agar and
processed for embedding in "Araldite" epoxy resin. 1J.lI11 thick sections of
the cell pellet were examined to find areas with a high cell density which
were then ultra thin sectioned. The 100nm sections were negatively
stained and examined by transmission E.M. to look for cells with
phagosomes containing bacteria and lysosome marker.
2.2.8. SDS-PAGE AND WESTERN BLOTTING
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) of proteins was performed in gradient 10-20% acrylamide
vertical slab gels using the Laemmli (1970) buffer system. Pre-cast 8-25%
gels were also used with the Pharmacia Excel gel and Phast
horizontal electrophoresis systems. Samples were dissociated at 1000C
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for 5 min in 0.0625M Tris HCI buffer pH 6.8 containing 2% SDS,
5% 2-mercaptoethanoI, 10% glycerol and bromophenol blue. In some
cases 2-mercaptoethanol was omitted to look for proteins containing di-
sulphide bonds. Protein loading on the slab gels was 25-30Jlg, 10-20Jlg
was loaded on Excel gels and 1ug on the Phast gels. Molecular weight
markers were Sigma, Dalton VII-L (14,200, 20,100, 24,000, 29,000,
36,000, 45,000 and 66,000 Da). Electrophoresis was at 200V constant
voltage over 20h for vertical gels, 45mA constant current over 2-3 hours
for Excel gels and 250v, 13mA for 40 min with Phast gels. Gels were
stained with Coomassie blue or a silver stain for proteins (Bio-Rad).
Proteins in unstained gels were transferred onto nitrocellulose using a
semi-dry electro-blotter (Bio-Rad) at 3mNcm2 of gel for 30 min.
Following incubation with 3% gelatin in 50mM Tris buffered saline
(TBS) pH 7.4 containing 0.05% Tween 20 (TTBS) the nitrocellulose was
stained immediately or stored at -20OC. These blots were
immunostained using a procedure described by Newell (1987). Following
incubation with antisera, bound antibody was recognised with anti-rabbit
or anti-guinea pig IgG conjugated to Horseradish peroxidase (HRP)
which was visualised with 3-amino 9-ethyl carbazole as substrate.
2.2.9 ANTISERA
Antisera were raised in rabbits to whole, live, virulent and avirulent
strains and to surface protein preparations. Rabbits were immunised as
described by Conlan & Ashworth (1986).
Guinea pig anti-L.pneumophila antibodies were obtained from animals
which had received sub-lethal doses of virulent strains and non-lethal high
doses of avirulent strains.
Development of antibody by the animals was monitored by ELISA and
immunoblotting techniques.
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Antiserum to L.micdadei macrophage infectivity potentiator (mip,
Cianciatto et al., 1989b, Bangsborg et al., 1991) was a generous gift from
Dr. Jette Bangsborg, Statens Seruminstituts, Copenhagen, DK.
2.2.10. ABSORPTION OF ANTISERA
An adsorption technique was used to remove cross-reacting antibodies
from certain of the antisera. A working dilution of the antiserum was
incubated with an appropriate bacterial strain at a concentration of 1011
organisms for 1 hour at 370C with constant rotation then stood overnight
at 40C. Following centrifugation to remove bacteria the antiserum was
absorbed twice more. The efficiency of removal of antibodies was
assessed by ELISA.
2.2.11. ELISA
The ELISAs used to screen for specific antibody production were similar
to that described by Conlan & Ashworth (1986) where antigen was
coated on microtitre plates and antigen-specific antibody detected by anti-
rabbit or guinea pig IgG conjugated to Horseradish peroxidase (HRP)
using tetramethyl benzidine as substrate.
2.2.12. LPS PREPARATIONS
Virulent and avirulent strains grown in YEB were harvested and a hot
saline extraction of LPS prepared by the method of Conlan and Ashworth
(1986). The extracts were separated on linear 15% acrylamide gels
containing 4M urea and stained for LPS by the Tsai and Frasch (1982)
silver stain.
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2.2.13. EXTRACELLULAR ENZYME ASSAYS
Extracellular enzyme production by virulent and avirulent strains was
compared by analysis of the supernatant following 18 hour culture in
YEB and also by growth of strains on agar into which enzyme substrates
were incorporated.
Tissue destructive protease (TDP) (Conlan et al., 1986) activity was
identified by casein precipitation whilst chromogenic p-nitroanilide
substrates were used to show activities of leucine, lysine and alanine
amino peptidases, acid phosphatase (Conlan et al., 1986) and
phospholipase C (Baine, 1985).
2.2.14. SURFACE STRUCTURE ANALYSIS
Colonies of virulent and avirulent strains were scraped from BCYE agar
following 3 days incubation at 370C and suspended in distilled water. The
suspensions were vortexed for 15 seconds three times to shear off any
loosely bound material. Bacteria were removed by centrifugation
followed by passage through a 0.45Jlffi pore diameter filter. The
filtrate was concentrated by freeze-drying or by ultra centrifugation at
100,000g and analysed by SDS-PAGE and electron microscopy. Rabbit
antiserum to this material was raised and used for immunolabelling
techniques.
2.2.15. PREPARATION OF CELL WALLS
Whole bacteria were scraped from BCYE plates following 3 day
incubation and suspended in HEPES buffer pH 7. Suspensions
containing approximately 1010_1011 organisms mI-} were subjected to
repeated bursts of 20,000 lbslsq inch pressure in a French pressure cell.
Broken bacterial suspensions were centrifuged to remove debris and the
cell wall material pelleted in an ultracentrifuge at 100,000g. The cell
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walls were washed in HEPES, then treated with 2%) sarkosyl in HEPES
containing 7mM EDTA at 370C for ]h with vigorous mixing every ] 5
min. The insoluble outer cell wall material was pelleted from the soluble
inner membrane by centrifugation and the detergent removed from the
soluble material by dialysis.
The cell walls and inner cell membranes of virulent and avirulent strains
were analysed by SDS-PAGE following each of the above procedures.
2.2.16. IMMUNOCYTOCHEMISTRY
Immunolabelling of antigens by electron and light microscopy was
performed as described by Williams et al. (1987). Immunogold labelling
was used to identify surface antigens on whole organisms taken from
BCYE agar and an indirect immunoperoxidase technique used to
investigate in vivo expression of these antigens in sections of lungs from
guinea pigs with experimental LD.
2.2.17. EXTRACTION OF PROTEINS BY DETERGENTS
Outer membrane preparations and whole bacteria were treated with the
following detergents: MEGA-I0 (decanoyl-Nimethylglucamide); MEGA-8
(Octanoyl-Nsmethylglucamide); n-Octylglucoside; Thesit (dodecylpoly-
(ethyleneglycolether)n); CHAPS (3-[ (3-Cholamidopropyl)
dimethylammonio ]-I-propane-sulphonate); CHAPSO (3-[(3-
Cholamidopropyl)dimethylammonio ]-2-hydroxy-l-propane-sulphonate.
Solutions (10% w/v) of the detergents were prepared in 50mM phosphate
buffer containing 7mM EDTA. 20111of detergent solution was added to
Iml of bacterial suspension (approximately 1010 cells ml-I) and to Iml of
outer membrane protein preparations (approximately 2mg ml+). Following
incubation at 370C for 1 hour the detergent extracts were separated from
the insoluble pellets and both analysed in gradient Excel and Phast gels.
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2.3. RESULTS
2.3.1. VIRULENCE OF STRAINS
Virulent strains Corby (CV), Stafford (SV) and Dodge (DV) and their
avirulent counterparts (CA, SA and DA) were given to guinea pigs as a
small particle aerosol to determine their virulence in terms of ability to
cause disease and death. The LDso's and survival rates of the animals are
given in Fig.2.2. Virulent strains caused illness typical ofLD in the guinea
pig with death occurring between 3-4 days whereas the derived avirulent
strain was not lethal for the animals even when administered at the
maximum dose possible (hence the LDso value is expressed as being
greater than 1 x 106 c.f.u'/ lung).
After 32 passages on BCYE the Corby strain became completely
avirulent (CAC) in the guinea pig model (Jepras et al., 1985). Stafford
and Dodge strains did not convert to avirulent forms after subculture 94
times on BCYE (Slayne and Fitzgeorge, unpublished) but were avirulent
after single passage on MHIH.
Once passaged the avirulent strains were able to grow on MHlli but
virulent parent strains and CAC did not.
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Fig.2.2. LDso values for L.pneumophila strains in guinea pigs infected by
the aerosol route.
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2.3.2. UPTAKE AND INTRACELLULAR MULTIPLICATION OF
STRAINS BY MACROPHAGES IN VITRO.
The in vitro guinea pig macrophage assay was used to compare uptake
and intracellular multiplication of the virulent and avirulent forms of the
Corby strain.
Uptake of strains by macrophages from 20-120 min was similar for each
of the strains in anyone experiment. Fig.2.3. shows the results of three
assays where strains were taken up to the same extent over 120 min in
each experiment although there were variations, between assays, in the
numbers of bacteria ingested over the time period.
Fig 2.4. shows the change in numbers of intracellular organisms over
48h. CV multiplied by 2 loglO c.f.u. greater than the Oh count, CA
increased less than one loglO c.f.u. and CAC decreased by 3 logs.
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Fig.2.3. Uptake of Corby strains. by guinea pig macrophages in vitro.
Three experiments are shown, marked 1,2, and 3.
• - CV, • - CA, • - CAC.
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Fig.2.4 Intracellular multiplication of Corby strains m gumea pig
macrophages maintained in cell culture over 48 hours. Solid symbols
represent mean values of experiments, open symbols represent range of values .
• - CV , • - CA .&- CAC .
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2.3.3. GROWTH OF STRAINS IN GUINEA PIG LUNG LAVAGE
Viable counts of CV and CA in cell-free L.pneumophila-infected and
uninfected guinea pig lung lavages are shown in Fig.2.5. When compared
with growth in YEB both strains exhibited little or no multiplication.
The virulent bacteria lost viability in the various lavages over 24 hours
and were undetectable after 48 hours suggesting that the lavages were
inhibitory. However in a second experiment viability was maintained in
normal lung lavage over 48 hours. Viability of avirulent Corby decreased
slightly over 48 hours in normal lavage and increased slightly in infected
lavage. Lavages which had been concentrated (as described in the methods
section) had similar effects on the growth of CV and CA as above.
Addition of ferric pyrophosphate to the lavages did not alter the results
(data not shown). In general, survival of the avirulent bacteria was better
than the virulent bacteria.
2.3.4. PHAGOSOME LYSOSOME FUSION
Labelling of lysosomes was not successful with either Thoria sol or
Colloidal gold. The Thoria sol was not confined to the lysosomes and was
too amorphous to be clearly distinguishable from components of the
cytoplasm. The colloidal gold could not be seen in the lysosomes.
Macrophages examined by electron microscopy 24 hours after infection
with CV in tissue culture revealed that lysosomes in the vicinity of
Legionella-filled phagosomes appeared to be discharging their contents
into the phagosome via a disintegrating membrane. A typical example is
shown in Fig.2.6.
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Fig.2.5. Survival of Corby strains in cell-free lung lavages of infected and
uninfected guinea pigs. LoglO viable counts are the mean of 3 tests. Two
experiments with normal lavage fluid are shown and one experiment with
infected lavage and concentrated, infected lavage.
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Fig.2.6. Electron micrograph of a guinea pig macrophage 24 hours after
infection with virulent L.pneumophila showing lysosomes (L) fusing with a
Legionella-filled phagosome (x 10,000). Insert is the area at higher
magnification (x19,000) to show disintegration of phagosome membrane
(Md) as compared with an intact membrane (Mi, centre, main picture).
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2.3.5. LPS
Crude preparations of LPS were prepared and analysed by SDS-PAGE on
a 15% gel containing urea. This silver-stained gel is shown in Fig.2.7.
The ladder banding pattern typical of L.pneumophila LPS serotype 1 was
seen in all the strains and there was little difference between virulent and
avirulent strains.
2.3.6. ENZYME ASSAYS
The extracellular enzyme activities of the three pairs of virulent and
MHIH avirulent strains were compared. Table 2.1 shows that all strains
(when grown on ABCD agar or in YEB) had the same enzyme
activities qualitatively.
I
Table 2.1. Extracellular enzyme assays of virulent and avirulent strains
STRAIN
CV CA CAC SV SA DV DA
Enzyme substrate ~ ~ ~ ~ ~ ~ ~
Casein ~ ~ ~ ~ ~ ~ ~
LeucinepNA ~ ~ ~ ~ ~ -v ~
LysinepNA ~ ~ ~ ..J ..J ..J ..J
A1aninepNA ..J ~ ..J ..J ..J ..J ..J
pNA phosphate ~ ~ ~ ~ ~ ..J ~
phosphoryl choline ~ ~ NT ..J ..J ..J ..J
_QNA
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Fig.2.7. SDS-PAGE.analysis of virulent and avirulent strain crude LPS
preparations in a 15% acrylamide gel containing 4M urea.
1. CV;
2. CA;
3. SV;
4. SA;
5. DV;
6.DA.
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2.3.7 SURFACE PROTEINS
The surface material obtained by vortexing whole organisms was
analysed by SDS-PAGE (Fig.2.8). A 45kDa protein band was found to be
present in much greater quantity on virulent organisms than avirulent.
When examined by electron microscopy this material consisted mainly
offlagella, fimbriae and a lattice-type cell wall structure (Fig.2.9).
Antisera raised against the flagellar material contained anti LPS
antibodies as determined by ELISA and also, on Western blots, reacted
strongly with the 45kDa band. To determine whether this band was
flagellin the antisera were adsorbed with CA (which contains few
flagella) to remove anti LPS antibodies. Fig.2.10, shows that the
antiserum no longer reacts with LPS or CA flagella preparation but
stains the 45kDa band strongly. The adsorbed anti-flagella antiserum was
used to immunogold label whole bacteria and flagella preparations which
were then examined by transmission electron microscopy. Fig 2.lla
shows whole CV with labelled flagella, 2.11b shows a SV surface protein
preparation with flagella and unlabelled fimbriae and 2.11c shows a
flagella preparation from SA showing that the avirulent strains do
possess some flagella.
When used to immunoperoxidase label infected guinea pig lung tissue
the adsorbed anti-flagella antibody produced strong staining in the areas
of tissue damage which, in sections stained for LPS, contained most of the
bacteria (Fig.2.12).
2.8. OUTER MEMBRANE ANALYSIS
Outer membrane preparations (OMPs) of the pairs of strains following
sarkosyl extraction gave variable results on SDS-PAGE. Fig 2.13a shows
a gel ofOMPs made from one batch of bacteria in which a 24kDa band
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Fig.2.8. SDS-PAGE of surface proteins of virulent and avirulent strains.
1. CA; 6. SA; 11. DA;
2. CV; 7. SV; 12. DV;
3. CV diluted 112; 8. SV diluted 112; 13. DV diluted 112;
4. CV, 114; 9. SV, 114; 14. DV, 1/4;
5. CV, 1/8~ 10. SV, 1I8~ 15. DV, 1/8~
Mw, molecular weight markers as shown.
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Fig.2.9. Electron micrograph of surface proteins from SV. Flagella (F),
funbrae (Fm) and a lattice type structure (L) were observed.(x 142,000)
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Fig.2.10. Western blot of CV and CA surface protein and LPS
preparations immunostained with antiserum raised against virulent strain
surface proteins and adsorbed with whole avirulent strains.
1. CV surface protein prep.;
2. CA surface protein prep.;
3. CVLPS;
4. CALPS.
Molecular weight markers (Mw) stained with colloidal gold total protein
stain.
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Fig.2.11 Electron micrographs of whole bacteria and surface protein
preps. of virulent and avirulent strains immunogold labelled with
adsorbed anti-surface protein antibodies. The gold particles attached only
to flagella (F) and not to whole bacteria or fimbrae (Fm).
A. CV whole cells, x 40,000;
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Bc
B. SV surface protein prep x 100,000.;
C. SA surface protein prep x 50,000.
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Fig.2.12. Micrograph of a section of CV-infected guinea pig lung,
inununoperoxidase stained for flagella using serum absorbed to remove
antibodies against LPS. The brown areas represent labelled flagella. Tissue
counterstained with haematoxylin. x500 magnification.
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Fig.2.13. SDS-PAGE of outer cell walls and inner membranes of virulent
and avirulent Corby, Stafford and Dodge strains. Arrow marks virulent
strain-specific band. A and B, Outer cell walls, C, Inner cell membranes.
Lanes on A: 1. CA, 2. CV, 3. SA, 4. SV, 5. DA, 6. DV.
Lanes on B and C: 1. CV, 2. CA, 3. SV, 4. SA, 5. DV, 6. DA.
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(arrowed) was present in the virulent strains but not the avirulent. However
Fig.2.13.b shows OMPs which do not have this difference and is more
typical of subsequent preparations.
The sarkosyl solubilised inner membrane proteins are shown in Fig.2.13c,
these also exhibited much similarity between virulent and avirulent strains.
Fig.2.l4. is a gel of outer membrane preparations run under reducing
and non-reducing conditions. There were no differences between virulent
and avirulent strains but the arrows represent proteins seen with reduced
samples which were not present in the non-reduced samples.
2.3.9. IMMUNOSTAINING OF WHOLE ORGANISM AND OUTER
MEMBRANE PROTEIN BLOTS
Western blots of whole organisms and outer membrane preparations of
virulent and avirulent strains were stained with various antisera.
A) Reaction with monoclonal antibody 2.
Both virulent and avirulent strains reacted with a monoclonal antibody
which has been reported to react with clinical but not environmental strains
of L.pneumophila (MAb 2, Doumon et al., 1986) by immunofluoresence
(not shown) and by immunoblotting. Fig.2.15 is a representative blot of
the pairs of strains demonstrating an identical banding pattern for CV
as CA.
B) Polyclonal rabbit sera and sera from infected guinea pigs.
Similar staining patterns of protein bands were observed on western blots
of SV and SA whole bacteria when incubated with sera from rabbits
immunised with either whole SV or SA (Fig.2.16 lanes 1 & 2, 3 & 4).
There was however a slight difference in the intensity of staining of a
protein band in the region of the 24 kDa marker in that it was stronger in
the SV blots. When the SV and SA blots were incubated with sera from
guinea pigs which had been infected with SV there were fewer reactions
45
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Fig.2.14. SDS-PAGE of outer membrane preps. of virulent and avirulent
strains under non-reduced (lanes 1-4) and reduced conditions (lanes 5-8).
1. CV non-reduced; 5. CV reduced;
2. CA non-reduced; 6. CA reduced;
3. SV non-reduced; 7. SA reduced;
4. SA non-reduced; 8. SV reduced.
Position of molecular weight markers of 45 and 29 kDa are shown.
Protein bands found only under reduced conditions are marked (arrows).
46
1 2 Mw
-66
-45
-36
-29
-24
-20 1,
-142,
Fig.2.IS. Westen} blot of Corby virulent (lane 1) and avirulent (lane 2)
outer membrane preps immunostained with monoclonal antibody 2 (MAb
2) showing identical band pattems.
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Fig.2.16. Western blot of Stafford strain whole bacteria immunostained
with various anti-L.pneumophila sera. Odd numbered lanes are virulent
bacteria (SV) and even numbered lanes are avirulent (SA).
Antisera:
lanes 1 & 2, rabbit anti SV whole bacteria;
3 & 4, rabbit anti-SA whole bacteria;
5 & 6, serum from guinea pigs infected with SV;
7 & 8, serum from guinea pigs infected with SA.
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than those observed with the rabbit sera and even fewer when stained with
sera from guinea pigs infected with SA.
Fig.2.17 shows the results of staining Corby OMP blots. Staining
patterns of the protein bands were similar on the CV and CA blots
following incubation with rabbit sera. When the same blots were incubated
with sera from guinea pigs infected with CV and CA the intensity of
staining was less than with the rabbit sera but most of the protein bands
which had stained with the rabbit sera, were also observed with the guinea
pig sera. A high molecular weight band was observed only on CA blots
(arrow).
C) Anti-mip antibody
Western blots of whole bacteria and outer membrane preparations of the
Corby virulent and avirulent forms all showed positive reactions when
incubated with rabbit anti-L.micdadei mip (Fig.2.18). The strongest
reaction was with a band of around 24kDa but possible cross reactive
bands at 29,36, and 45kDa were also stained
2.3.10. DETERGENT EXTRACTIONS
The SDS-PAGE separation of proteins extracted from the
membranes of whole CV and CA organisms by a number of detergents
is shown in Fig.2.19. When incubated with either, phosphate buffer
containing EDTA, the non-ionic detergent, octylglucoside (Fig.2.19a) or
the zwitterionic CHAPS and CHAPSO (Fig.2.19b), the same protein
bands were found in CV as CA and these were similar for each
detergent. Extraction with the detergent, MEGA 10 resulted in a difference
in protein bands between CV and CA (Fig.2.19c). A low Mw «14kDa)
was seen in greater quantity in CV than CA. This band was also
prominent in the CV whole bacteria and when the pellets of the detergent
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Fig.2.17 . Western blot of Corby strain outer membrane proteins with
various anti-L.pneumophila sera. Odd numbered lanes are a virulent strain
preparation (CV) and even numbered lanes are avirulent (CA).
Antisera:
1 & 2, rabbit anti CV whole organisms;
3 & 4, rabbit anti-CA whole organisms;
5 & 6, senun from guinea pigs infected with CV;
7 & 8, senun from guinea pigs infected with CA.
Molecular weight markers (Mw) and CV stained with colloidal gold total
protein stain. The arrow marks a possible avirulent strain specific band
referred to in the text.
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Fig. 2.18. yvestern' blot of Corby strains immunostained with rabbit
antiserum to L.micdadei m.i.p. protein.
Lanes: 1. CV whole bacteria;
2. CA whole bacteria;
3. CAC whole bacteria;
4. CV outer membrane preparation;
5. CA outer membrane preparation.
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Fig.2.19. SDS-PAGE of detergent extracts of Corby virulent and avirulent
strains. 8-25% Pre-cast gradient gels, silver stained.
A. 1. CV + EDTA buffer; B. 1. CV + CHAPS~ c. 1. CV whole organisms
2. CA + EDTA buffer; 2. CA + CHAPS 2. CV +Mega 8
3. CV + octylglucoside; 3. CV + CHAPSO; 3. CA +Mega 8
4. CA + octylglucoside. 4. CA + CHAPSO. 4. CV +Mega 10~
5. CA +Mega 10.
52
extracted strains were analysed the band was present in all the CV but
not CA (Fig.2.20a lanes 1-8, 2.20b lanes 8-17) samples and was absent
in CA whole organisms (Fig. 2.20b lane 2). However, analysis of
Stafford and Dodge showed a band at the same position on the gel in
both virulent and avirulent whole organisms (Fig.20b lanes 3-6). CAC also
contained the band (20b lane 7).
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Fig.2.20. SDS-PAGE of the insoluble pellets of virulent and avirulent strain
detergents 8-25% Pre-castwhole cells following incubation with various
gradient gels, stained with Coomassie blue.
A. Lanes: 1,3 & 5. CV +Mega 8;
2,4 & 6. CA +Mega 8;
7. cy +Mega 10;
8. CA +Mega 10.
1. cy control (no detergent);
2. cA control;
3. SV control;
4. SA control;
5. DV control;
6. DA control;
7. CAC control;
BLanes: 8. CV + octylglucoside;
9. CA + octylglucoside;
10. CV + CHAPS;
11. CA + CHAPS;
12. CV + CHAPSO;
13. CA + CHAPSO;
14 & 16. CV + buffer
15 & 17. CA + buffer.
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2.4. DISCUSSION
The conversion of L.pneumophila to an avirulent form by subculture on
Mueller Hinton agar (MHIH) was first documented by McDade and
Shephard (1979) and since then several workers have investigated this
phenomenon (Wong et 01, 1981, Elliot and Johnson, 1982, Horwitz, 1987,
Catrenich and Johnson, 1988) . In those studies virulence was assessed in
embryonated hens eggs or guinea pig intraperitoneal or intratracheal
infection models. Varying degrees of virulence attenuation were described
for bacteria which had been passaged on MHIH at least 5 times. The results
presented in this study demonstrate that highly virulent strains of
L.pneumophila, following a single passage on MHIH, were completely
avirulent in a guinea pig aerosol infection model of Legionnaires' disease.
Virulent and avirulent forms of the Corby strain were incubated with guinea
pig alveolar macrophages in tissue culture, and the virulent strain (CV)
multiplied intracellularly over a 48 hour period, resulting in destruction of
the cell monolayer. The MIDH-derived avirulent strain (CA) neither
multiplied in nor affected the physical appearance of the macrophages.
Another avirulent form of the Corby strain, derived from passage on BCYE
agar (CAC), was also unable to multiply within macrophages but differed
from CA in terms of its intracellular survival. The BCYE derived strain did
not survive intracellularly but the MIDH avirulent strain remained viable
over 48 hours. This may indicate that the inability of the avirulent strains to
cause disease in guinea pigs was due to a susceptibility to different host
defence mechanisms.
The in vitro assay suggested that guinea pig macrophages were unable to
kill CA. If this is also the case in the lungs, it is possible that the mechanism
of clearance is destruction by polymorphonuclear phagocytes (PMNs). An
increased oxidative burst by PMNs in response to MHIH derived strains
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compared with the parent virulent orgamsm has been described
(Summersgill et ai, 1988). The virulent form of the Corby strain used in this
study has been shown to be susceptible to PMNs in vitro (Jepras &
Fitzgeorge, 1986) and in vivo (Fitzgeorge et ai, ]988) and it is likely that the
avirulent strains would also be readily killed by these cells. The fate of the
Corby strains in vivo was studied in relation to lung phagocytes and is
described in Chapter 3 of this thesis.
The avirulent form which had been attenuated on BCVE was unable to
grow on MIllH supporting the theory that attenuation on the two types of
media resulted in different changes in each but the overall effect was that
both were avirulent in guinea pigs.
The importance of intracellular growth for the pathogenesis of
L.pneumophila was confirmed in these studies by an inability of any of the
strains to grow in guinea pig lung lavage even when this was obtained from
infected animals. This implies that the large numbers of extracellular
bacteria seen in lungs of guinea pigs during experimental LD (Baskerville et
al., 1983, Williams et al., ]987) had been released from macrophages.
The behaviour of MHllI avirulent strains in the in vitro assay agree with
those of Horwitz (1987) who characterised MInH mutants of the
Philadelphia 1 strain and found that avirulent forms remained viable within a
phagolysosome but were not able to multiply. Horwitz suggested that
virulent strains inhibited phagosome-lysosome fusion thereby evading the
bactericidal mechanisms of the macrophage but that the avirulent organisms,
although not destroyed by the lysosome contents were unable to multiply.
Rechnitzer & Blom (1989) have shown that phagosome lysosome fusion in
human alveolar macrophages infected with L.pneumophila occurs whether
the strains are virulent or not. It was not possible to determine whether the
three forms of the Corby strain inhibited phagosome lysosome fusion in the
early stages of infection but some evidence of fusion was found in electron
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micrographs of macrophages 24 hours after infection with CV. This supports
the findings of Rechnitzer & Blom, (1989) and suggests that strains which
can multiply intracellularly are more likely to be resistant to the anti-
microbial strategies of macrophages rather than just able to evade them ..
There is evidence that both virulent and avirulent strains are highly
susceptible to the toxic oxygen metabolites produced by stimulated
phagocytes (Locksley et al., 1982, Jepras and Fitzgeorge, 1986) however
inhibition of the oxidative burst of phagocytic cells by virulent
L.pneumophila has been described (Summersgill et al., 1988 and 1990,
Rechnitzer et al., 1987) with virulent bacteria being slightly more
inhibitory than avirulent. The oxygen-dependent mechanisms are not the
only anti-microbial defences and if phagosome-lysosome fusion occurs the
bacteria must also resist attack by lysosomal enzymes. Leishmania
amazonensis amastigotes are able to resist oxygen-independent anti-
microbial systems of macrophages and are able to grow in an environment
of increased lysosomal enzyme activity (Prina et ai, 1990). It is possible
that this also applies to L.pneumophila. Virulent strains of L.pneumophila
have been reported to inhibit acidification of phagosomes (Horwitz and
Maxfield 1984) which may reduce activity of lysosomal enzymes, such as
acid phosphatase, that require a low pH. It is not known if MHIH mutants
inhibit acidification or lysosomal enzyme activity and assays to compare
enzyme activity levels in CV and CA infected macrophages may reveal
this. Relative susceptibilities of CA and CV to lysosomal enzymes such as
cathepsins and dipeptidyl peptidases and to disrupted whole
macrophages from normal or infected guinea pigs may reflect differences
in intracellular growth. The MHIH avirulent forms must resist killing to a
certain extent since viability is maintained within macrophages over 48
hours. Thus the key to whether these strains multiply or not could be
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components of the lysosome to which virulent forms are resistant and
avirulent forms are, at least partially, susceptible.
The reason for the loss of virulence of MHIH strains was confirmed to be
an inability to multiply within alveolar macrophages. To determine why
this may be so, CV and CA were compared physically, biochemically, and
immunologically in an attempt to identify a defect in some of the
pathogenic and virulence factors which have been described for other
bacteria which cause disease in humans.
Gram negative bacterial pathogens have a particular type of pathogenic
mediator in the form of LPS. Whilst the lipid A part of this molecule is
responsible for many of the pathological effects of infection such as
inflammation, fever and intravascular coagulation, the repeating
oligosaccharide units of the outer region (O-antigens) confer to the bacteria
resistance against host defences such as the effects of complement and
PMN bactericidal strategies. Alterations in the (LPS) structure of
Salmonella typhimurium have been correlated with loss of virulence and
changes in the interaction of the bacteria with macrophages and
complement (Liang-Takasaki et al 1982, 1983). In this study, LPS
preparations of all three of the virulent and avirulent strains of
L.pneumophila were compared by SDS-PAGE and no differences were
seen in the O-side chain ladder banding pattern. A biochemical alteration
which would not be apparent by SDS-PAGE may have occurred in the LPS
of the avirulent forms, but in previous studies (Conlan, 1987) has shown
that there was no difference in the quantity or chemical composition of LPS
preparations of CV and CAC. That study and the results reported here
suggest that LPS is not a critical virulence determinant for L.pneumophila
although it is probably involved in the disease process once infection has
been established. The reaction of serogroup 1 L.pneumophila strains with
certain monoclonal antibodies has been reported to be related to virulence.
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Doumon et al., (1986) found that the majority of environmental isolates
reacted only with a monoclonal antibody designated type 1 while clinical
strains reacted with type 2. The virulent and avirulent strains in this study
both reacted with type 2 indicating that this reaction is not an in vivo
virulence marker. This monoclonal antibody is directed at an LPS epitope
so the identical reaction of virulent and avirulent forms also suggests that
the virulence attenuation on culture medium does not affect LPS structure.
The reaction of strains with MAb 2 indicates the likelihood of an isolate
being environmental or clinical but it is not necessarily an indicator of the
virulence of that strain. The avirulent bacteria used in this study were
derived from clinical isolates and, whilst they had lost the appropriate
mechanism to cause disease in guinea pigs, they had retained the epitope
specific for MAb 2. It is possible that Legionella LPS undergoes minor
changes during passage through the host which could account for an
alteration of an epitope from that seen in the environment. In that case
monoclonal antibody 2 is not a marker of the potential virulence of a strain
but more likely provides evidence of strains which have caused disease.
Bacterial enzymes can also determine the severity of disease but some are
also virulence factors. Strains of Pseudomonas aeruginosa which do not
produce certain extracellular enzymes were less virulent in experimental
models (Holder & Haidaris, 1979). When the extracellular enzyme activities
of the L.pneumophila virulent and avirulent strains, grown in vitro, were
compared, the avirulent strains had the same activities as the virulent strains.
However, since the avirulent strains did not multiply in vivo, any pathogenic
effects which the enzymes exert would not be exhibited. Thus the ability to
produce a potential pathogenic factor in vitro is only relevant if that factor is
produced in sufficient quantities in vivo. The possible role of extracellular
proteases in the pathogenesis of LD is discussed in Chapter 4 of this thesis.
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The role of flagella and pili in the disease process is very clear for
pathogens which require these structures for attachment to host cells. The
ability of enterotoxigenic Escherichia coli to adhere to epithelial surfaces in
the intestine is mediated by pili which are therefore essential for
establishment of infection. Salmonella strains depend on flagella for
attachment and colonisation of the gut epithelial cells. A striking physical
difference between virulent and avirulent strains in the present study was the
47kDa protein band seen following SDS-PAGE of the surface proteins.
Further investigation demonstrated this to be flagellin and EM studies
confirmed that virulent strains had far more flagella than their avirulent
counterparts. Since L.pneumophila is a water born organism the possession
of flagella would be more of an advantage for motility in that environment
rather than to multiplication in lungs. The loss of flagella following culture
on MHIH has been reported by Elliot and Johnson (1982) who concluded
that flagella were not required for virulence in guinea pigs infected
peritoneally. It would seem unlikely that flagella were important for
virulence in the aerosol model since the shearing forces involved during
aerosolisation of bacterial suspensions would probably have removed most,
if not all, the flagella. Uptake of legionellae by macrophages was not
dependent on flagella since the avirulent strains, with less flagella, were
phagocytosed in similar numbers to virulent strains. Thus there does not
appear to be a role for flagella in the early stages of disease but, following
multiplication in the macrophage, the virulent organisms were very active
and could be seen to move independently within the cells in a manner
similar to that described by Rowbotham (1980) within amoebae. Once
released from the macrophages these organisms were extremely motile
(when observed by phase contrast microscopy) compared to the BCYE
grown equivalent. The expression of large quantities of flagella during
infection was confirmed by immunocytochemical staining of lung sections
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with absorbed (to remove anti-LPS antibodies) anti-flagellin antiserum
which revealed intense staining in the areas of infection. Increased motility
in the lungs could be advantageous in allowing, for example, the bacteria to
respond rapidly to chemotactic gradients which may aid survival and
multiplication of L.pneumophila, in vivo.
If possession of flagella is not related to virulence the differences between
the virulent and avirulent cells could be attributed to growth conditions and
metabolic state of the organisms in the various environments examined.
Several factors such as temperature, growth phase and nutrient availability
are known to alter expression of flagella by L.pneumophila (Dennis, 1986,
Mauchline, 1992 ) MHIH is a poor growth medium for L.pneumophila and
those bacteria which do grow have reduced expression of flagella. Similarly,
the legionellae seen moving rapidly within and out of macrophages in cell
culture were more motile than the same organism grown on BCYE because
the former were likely to be in a more active growth phase.
Another type of surface structure seen in these studies were fimbriae which
were present on both virulent and avirulent strains indicating that attachment
to surfaces is not important for L.pneumophila to cause disease.
Outer cell wall proteins are important for the structural integrity of
bacteria, to facilitate passage of materials in and out of the cell via
transmembrane channels and some are receptors or ligands. Membrane
proteins of various intracellular pathogens have been identified as possible
or actual virulence determinants, An outer membrane protein of Salmonella
typhimurium responsible for the resistance of the organism to the oxygen-
dependent killing mechanisms of polymorphonuclear neutrophils is an
important virulence determinant for the organism (Stinavage et al., 1990).
The cross linking of outer membrane proteins of Chlamydia is important in
determining the structure of the cell wall and the conversion between
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infectious and non-infectious forms of the organism (Newhall and Jones,
1983, Bavoil et al., 1984).
Several proteins in the outer cell wall of legionellae have been described
(Ehret and Ruckdeschel, 1983, Gabay et ai, 1985, Pau et ai, 1988, Sampson
et ai, 1990) and some have been suggested as pathogenic factors (Cianciotto
et al., 1989a). Two such proteins are the major outer membrane protein
(MOMP) described by several workers (Ehret and Ruckdeschel, 1983,
Rindahl and Iglewski, 1984, Butler et al., 1985 ) and the macrophage
infectivity potentiator (mip) protein identified by Cianciotto et al., (1989b).
The role of the MOMP of L.pneumophila in virulence has been implied by
its ability to bind to the complement receptor of macrophages which would
facilitate uptake of the bacterium, a process essential for multiplication of
legionella (Bellinger-Kawahara & Horwitz, 1990). In the present study there
were no differences in phagocytosis of the virulent and avirulent strains by
alveolar macrophages. Virulent and avirulent strains both expressed an outer
cell wall protein with the characteristics of the MOMP i.e. a 29kDa band
which was only observed on gels run under reducing conditions indicating a
protein having interchain disulphide bonds. The MOMP was therefore not a
virulence determinant of these strains and, whilst phagocytosis of
L.pneumophila is required for virulence, it is not the only important factor
since uptake of avirulent strains does occur.
The principal role of alveolar macrophages is to ingest and destroy foreign
particles and invading micro-organisms therefore legionellae will tend to be
phagocytosed by such cells. Intracellular survival and initiation of
multiplication, on the other hand, require the bacteria to elaborate factors
which overcome the natural destructive role of macrophages. The
Legionella mip protein has been shown to have a key role in the initial
stages of intracellular events by interfering with the oxidative response of
macrophages by inhibiting phosphorylation of protein kinase C (Engleberg,
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1993). However, mutants which do not express mip are only inhibited in the
early stages of infection and intracellular multiplication of mutants occurs in
a variety of cell types albeit more slowly than that of strains expressing mip
(Cianciotto et al., 1989b, Engleberg & Eisenstein 1991).
The avirulent strains in this study lost expression of a protein the same
molecular weight as mip (24kDa) but the bacteria were defective in
intracellular replication not just initiation of infection. Western blots of the
avirulent strains stained with anti-mip antibodies confirmed that mip was
expressed in avirulent strains. The loss of the 24kDa band in the avirulent
strains was not a consistent finding either in repeat gels of the same outer
membrane preparations nor when fresh batches were prepared. It is not clear
why this is so, though several possibilities exist. A contaminating protein of
similar molecular weight may have been present in avirulent strain
preparations, the source of which could even have been a population of
virulent organisms in the original suspension of bacteria from which the
membranes were prepared. Mixtures of mutant and wild-type bacteria could
be possible since the avirulent strains were derived from a single passage on
MHlli and not by successive cloning of avirulent bacteria. Membranes
prepared from suspensions of cloned bacteria might resolve this problem.
Multiplicity of bands in this region of the gels resulted in uncertainty as to
whether, in the later gels, the 24kDa band disappeared from virulent or
appeared in avirulent strains. Proteolysis of the band occurring in only
avirulent preparations seems unlikely. Variations in pouring consistent
gradient gels could also have contributed to the problem because of poor
resolution of bands. With the exception of mip there have been no reports of
a virulent -strain specific 24 kDa band which may explain the irregularity
of its appearance in this study.
To improve the reproducibility of the SDS-PAGE, pre-cast gradient gels
for use with horizontal electrophoresis were used to analyse whole cells and
63
detergent extractions. The similarity of the protein profiles following a
number of detergent extractions ( figs 2.19 & 2.20 ) indicated that proteins
on the surface of the bacteria were well conserved and varied little between
virulent and avirulent forms. Horwitz (1987) did not find any differences in
protein profiles between virulent and avirulent strains. The reaction of
Western blots of the pairs of strains with various specific antisera also
displayed a similarity in surface proteins. Antibodies in the sera against LPS
may have confused these results since LPS can co-migrate with proteins as
protein-LPS complexes during SDS-PAGE and give the appearance of a
reactive protein band (poxton et al., 1985). This is demonstrated in fig 2.15
where Western blots of CV and CA reacted with MAb 2 in such a way as to
suggest protein bands, yet the specificity of the MAb is for LPS.
The low molecular weight band found in Corby virulent strain, whole
organisms and detergent-extracted pellets has not been described elsewhere
but, since Stafford and Dodge avirulent strains and CAC contain the same
band (Fig.2.20), it is unlikely that it is a virulence determinant,
The fact that the macrophages in the in vitro assay appeared undamaged by
the avirulent strains, even when viable bacteria were present, suggests that
the mere presence of bacteria does not harm the macrophage and growth of
L.pneumophila is required for the cell destruction, possibly mediated by
Legionella protease which has been detected intracellularly in guinea pig
and human alveolar macrophages ( Chapter 4, this thesis, Rechnitzer et al.,
1992). This again demonstrates that the possession of a single virulence or
pathogenic factor by a micro-organism is not necessarily the key to causing
its disease 'since a full complement of such factors is often required before
infection is established.
The use of the macrophage assay enabled a characterisation of virulence
but clearly other mechanisms are involved in the host response in vivo. The
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next Chapter describes experiments which study the response of the guinea
pig host to the virulent and avirulent strains.
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CHAPTER3
Virulence of Lpneumophila in vivo
3.1. INTRODUCTION
Removal of anyone component that contributes to a pathogens' ability to
cause disease mayor may not result in an avirulent strain. The importance of
such a factor depends as much on the host and prevailing circumstances in
vivo as it does on the other contributing factors of the organism.
The environment of artificial culture media IS, for many pathogens,
different to that which they encounter in vivo yet the majority of
investigations carried out on these pathogens are performed on bacteria grown
on such media.
It is now clear that artificial growth media can drastically alter strains of
L.pneumophila from the original clinical or environmental isolate. Chapter 1
of this thesis describes the results of passage of the Corby strain of
L.pneumophila on MI-llH and BCYE agars and confirms previous reports that
avirulent forms of the organism are produced. However, despite extensive
analysis of these strains a factor or factors responsible for loss of virulence
could not be found. A number of environmental factors such as temperature
(Ogg et al., 1958; Maurelli & Sansonetti, 1988), and nutrients (Robinson et al.,
1983), have been found to influence the expression of bacterial virulence
determinants and such parameters have also been shown to affect the virulence
of L.pneumophila (Edelstein et ai, 1987). Several pathogens are known to
express a different set of proteins when exposed to their in vivo environment
to those expressed following growth on culture media. Salmonella
typhimurium synthesizes several novel proteins in the presence of epithelial
cells (Finlay and Falkow, 1989b) and upon infection of macrophages
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(Buchmeier and Heffron, 1990). Vibrio cholerae recovered from the gut of
infected animals expressed fewer cell envelope proteins than media-grown
bacteria and these proteins were not expressed during in vitro culture (Jonson
et ai, 1989). Stress induced proteins which are produced as a result of nutrient
depletion or exposure to toxic substances are also found. Hydrogen peroxide-
induced proteins are believed to play a part in the pathogenesis of
S.typhimurium (Fields et al., 1986) and, given the intra-cellular environment
in which virulent legionellae thrive and the known toxicity of hydrogen
peroxide to L.pneumophila (Hoffinan et al., 1983) these may be induced in
L.pneumophila. It is thus possible that the in vitro experiments which
compared the avirulent with the virulent forms of Corby did not identify a
factor associated with virulence because that was only induced in vivo.
A single passage of a strain on artificial media would be sufficient to switch
off the expression of stress-induced proteins so it is important to recover
bacteria directly from the in vivo environment. Using the guinea pig model of
LD already described, virulent L.pneumophila were obtained from infected
lungs and alveolar macrophages and compared with bacteria grown on
artificial media in terms of their ability to infect macrophages and expression
of surface proteins.
There is much evidence that the principal component of host defences with
which L.pneumophila interacts is the macrophage and several mechanisms by
which these bacteria can evade the anti-microbial defences of this cell have
been proposed. However, the vast majority of these studies have been
performed on macrophages cultured in vitro. Experiments described in
Chapter 2 have shown that the Corby strain variants behave differently to each
other within guinea pig macrophages which were cultured in vitro. The
fates of these organisms in vivo, following aerosol administration were
studied in order to investigate the role of macrophages in the early stages of
infection with virulent and avirulent legionellae.
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Whilst the role of macrophages in allowing multiplication of virulent
L.pneumophila and providing protection from host defences, is well
established, the contribution to bacterial clearance made by
polymorphonuclear leukocytes (PNMLs) is in debate. It has been suggested
that L.pneumophila is only partially susceptible to PMNL killing in vitro
(Horwitz & Silverstein, 1981) but that avirulent mutants are more
susceptible than their virulent counterparts (by inducing a greater oxidative
response) (Summersgill et al., 1988).However, virulent and avirulent strains
are equally susceptible to the toxic effects of the myeloperoxidase-HyOj-halide
systems of PMNLs in vitro (Locksley et al., 1982; Lochner et aI., 1983;
Jepras & Fitzgeorge, 1986) and depletion of PMNLs in the guinea pig model
of LD results in a decrease in LDso, demonstrating that these cells are
important in defence against L.pneumophila in vivo (Fitzgeorge et al., 1988).
In an attempt to clarify the role of these cells, the interaction of PMNLs with
virulent and avirulent forms of the Corby strain following aerosol infection of
guinea pigs was studied in parallel with macrophages. In conjunction with
conventional cell separation and bacterial culture techniques the use of flow
cytometry to monitor the cellular response of guinea pigs was assessed. Lung
phagocytes were identified by their size and granularity and antibody
markers used to fluorescently label cells and intracellularbacteria.
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3.2. MATERIALS AND METHODS
3.2.1. ISOLATION OF IN VIVO-GROWN L.PNEUMOPHILA.
Virulent Corby (CV) and Stafford (SV) strains were incubated for 48 hours
with macrophages in tissue culture, as described in Chapter 1. The culture
supernatant was then removed and any bacteria which were present were
collected by differential centrifugation (200g to pellet cell-debris then IOOOg
to pellet bacteria). The macrophages were repeatedly freeze-thawed to
release intracellular organisms which were collected by centrifugation as
above.
CV was also obtained from macerated lungs of gumea pigs with
experimental LD. Lungs were homogenised and bacteria pelleted from the
supernatant following centrifugation to remove tissue debris. Bacteria were
also isolated from homogenate supernatants using magnetic (Dynal)
beads. The bacteria were coated with a rabbit anti L.pneumophila
serogroup 1 LPS IgG then incubated with magnetic beads conjugated to
anti-rabbit IgG antibody. The bacteria-coated beads were removed from
homogenate supernatants by means of a strong magnet and, following
washing in buffer, the bacteria were released from the beads by incubation
at 370C for 1-2 hours.
3.2.2. PREPARATION OF ANTISERA TO IN VIVO GROWN
L.PNEUMOPHILA.
Guinea pigs were immunised with bacteria which had been isolated from
lungs of guinea pigs infected with CV and SV. Each suspension, containing
approximately 107 live bacterialml (by total count) was diluted in an equal
volume of Freund's incomplete adjuvant and mixed to produce a smooth
emulsion. Three guinea pigs were injected intra-muscularly (in the hind legs)
with 200J..llof the emulsion. After 2 weeks the animals were given the same
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doses as above and blood was obtained a week later. Sera were tested by
immunostaining of Western blots of BCYE grown and in vivo grown
bacteria (see below).
3.2.3. ANALYSIS OF IN VIVO GROWN LEGIONELLAE
The uptake and intracellular replication of in vivo grown CV by guinea pig
alveolar macrophages was compared with that of BCYE-grown CV using
the intracellular growth assay described in Chapter 1.
SDS-PAGE analysis was performed in gradient 10-20% acrylamide gels
which were then Western blotted as described in Chapter 1.
Nitrocellulose blots were immunostained with the following:
a) antisera raised in rabbits against CV and SV grown on BCYE;
b) convalescent sera from guinea pigs challenged with virulent and avirulent
strains;
c) antisera raised in guinea pigs against in vivo grown CV and SV.
3.2.4. CELLULAR RESPONSE OF GUINEA PIGS TO VIRULENT AND
AVIRULENT CORBY.
Guinea pigs were challenged with aerosols of CV, CA and CAC as
described in Chapter 1. At 0, 4, 8, 12, 24 and 30 hours following
infection 3 guinea pigs were sacrificed, Lungs of two of the animals were
washed out with tissue culture medium (MEMa, see Chapter 1 ). The lungs
were removed from the third and fixed in phosphate buffered formalin for
histopathology .
The volume of each lavage was measured then aliquots removed for
bacterial viable counts. Counts were performed on the whole lavage and, by
separation of cells and supernatant, on the intra- and extra-cellular
environments. The remainder of the lavage was centrifuged to pellet the
cells which were resuspended in 0.5 mI of MEMb (see Chapter I). Small
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volumes were removed for total white cell counts and cell smears which
were stained with Leishmans differential white cell stain. A portion of
the cells was taken into each of several tubes for immunolabelling (see
below) and the remainder diluted in 1 ml of MEMb and overlaid on a cell
density-separation medium (J prep).
3.2.5. IMMUNOLABELLING OF CELLS FOR FLOW CYTOMETRY
Monoclonal antibodies with specificities for the guinea pig cells under
study were not available, so the following were tested for cross-reaction:
mouse monoclonal anti-human HLA-DR, FITC conjugate (Dako) and
mouse monoclonal anti-human granulocyte, FITC conjugate (Dako). A
mouse monoclonal antibody of the same isotype, FITC conjugate negative
control (Dako) was used with these antibodies. To label bacteria, a rabbit
anti-L.pneumophila serogroup 1 LPS, FITC conjugate was used with rabbit
IgG, FITC conjugate negative control. Cells were incubated with antibodies
at room temperature for 30 minutes after which time, 3 ml of PBS was
added and the cells pelleted to wash off excess antibody. The pellets were
resuspended in 0.5 ml PBS containing 1% formaldehyde to fix the cells
and kill any bacteria.
3.2.6. FLOW CYTOMETRY
Samples were analysed in collaboration with Dr L.A.E. Ashworth with the
skilled assistance ofMrs.S.A. Sharpe on a Coulter EPICS PROFILE
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3.3.RESULTS
3.3.1. ISOLATION OF IN V7VO-GROWN L.PNEUMOPHlLA
Isolation of L.pneumophila from macrophages in tissue culture was more
successful than removal from infected guinea pig lung since macerated lung
material was difficult to remove by centrifugation. The use of magnetic
(Dynal) beads improved the separation but, as this method involves binding
antibodies to the bacterial surface, these bacteria could not be used for
Western blotting. The quantities of in vivo-grown bacteria were
subsequently very low and there was only sufficient of the Stafford strain to
immunise guinea pigs. The remaining experiments were performed using CV
isolated from macrophages in tissue culture.
3.3.2 UPTAKE AND INTRACELLULAR GROWTH OF IN VIVO
GROWNCV.
The uptake of in vivo-grown CV by guinea pig alveolar macrophages in
tissue culture was similar to that of the same strain grown on BCYE. Fig.
3.1 shows that for both types of bacteria the majority of the bacteria were
ingested after 20 minutes incubation and that further uptake occurred at
similar rates.
Intracellular multiplication of the media-grown CV occurred at a faster
rate than the in vivo-grown CV (Fig.3.2.) but, given the variations in
replication rate of strains in this assay (see Fig 2.3., Chapter 2), the
difference may not be significant.
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associated with guinea pig alveolar macrophages in tissue culture during
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3.3.3. SDS-PAGE AND WESTERN BLOT ANALYSIS OF CV, GROWN
IN VIVO
Insufficient quantities of in vivo grown SV were obtained for separation
by SDS-PAGE but antiserum was raised against these bacteria. The results
of immunolabelling blots of BCYE-grown bacteria with various antisera
are shown in Fig.3.3. Fewer antigens were recognised by antiserum against
in vivo-grown SV (Lanes 9 and 10) than by that raised in rabbits against
BCYE-grown SV strains (lanes 1-4) and even fewer by antiserum which
had been raised against SA recovered from macrophages. Similarly, the sera
taken from guinea pigs infected with the virulent and avirulent strains (lanes
5-8) reacted with fewer bands than the rabbit sera but showed some
differences to the pattern of staining with antisera to in vivo grown
bacteria.
A low molecular weight band was observed on both virulent and avirulent
blots which stained only when incubated with anti-in vivo-grown SV.
Contaminating proteins from the tissue culture medium prevented
interpretation of SDS-PAGE gels of in-vivo-grown CV stained for total
protein, therefore analysis was restricted to immunolabelling of Western
blots. Fig.3.4 is a comparison of blots of BCVE-grown CV (odd-
numbered lanes) with in vivo-grown CV (even-numbered lanes) stained
with the same types of antisera described above. In general, fewer protein
bands were found on in vivo CV blots than the paired BCVE CV blots and
no bands unique to in Vivo-grown CV were apparent.
In Vivo-grown CV appeared to demonstrate a reduced antigen expression
compared with BCYE-grown CV. Antibodies raised against in vivo CV
reacted strongly with bands at around 19kDa and 16kDa and also in the
region of the 36 and 45 kDa markers and it was only in these areas that the
in vivo grown blots reacted
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Fig.3.3 Western blot of Stafford virulent (SV, odd numbered lanes) and
avirulent (SA, even numbered lanes) strains irnmunostained with the
following antisera:
1 & 2, rabbit anti-SV whole bacteria;
3 & 4, rabbit anti-SA whole bacteria;
5 & 6, serum from guinea pigs infected with SV;
7 & 8, serum from guinea pigs infected with SA;
9 & 10, guinea pig anti-in vivo grown SV;
11 & 12, guinea pig anti-SA recovered from infected guinea pigs.
Molecular weight markers and SV incubated with colloidal gold total
protein stain.
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Fig.3.4. Western blot of BCYE-grown Corby (CV, odd numbered lanes)
and in vivo-grown Corby (even numbered lanes) immunostained with
the following antisera:
1 & 2, rabbit anti-CV whole bacteria;
3 & 4, rabbit anti-CA whole bacteria;
5 & 6, guinea pig anti CA recovered from infected guinea pigs;
7 & 8, serum from guinea pigs infected with CV;
9 & 10, serum from guinea pigs infected with CA;
11 & 12, guinea pig anti-in vivo grown Corby;
13& 14, rabbit anti-L.pneumophila serogroup 1 LPS.
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3.3.4. CELLULAR RESPONSE OF GUINEA PIGS TO VIRULENT AND
AVIRULENT CORBY
Over a period of 3 months small volumes of guinea pig lung lavages
(which were performed for various experiments) were taken and cell counts
performed. The results are given in Table 3.1. and show that, on average,
the cell population consisted of around 60% macrophages and 40%
granulocytes comprising PMNLs and eosinophils.
Table 3.1. Analysis ofnonnal guinea pig lung lavages, total and
differential white cell counts.
Total cell count Proportions of cell types (%)
(/ lung)
Granulocytes Macrophages
Mean 1.02 x 106 41.9 57.9
Range 0.3-1.8 x 106 19-55 45-81
Number of 16 20 20
animals
The changes in the relative proportions of these cell populations which
occurred following aerosol challenge of the animals with CV, CA and
CAC are shown in Fig.3.5. The PMNL population increased initially after
challenge with all three strains but after 4 hours these cells returned to
normal levels in animals given CA and CAC yet in animals given CV the
proportion of PMNLs rose further and became the dominant cell type (Fig.
3.5a). The eosinophil content of the lavage varied little throughout the
course of infection with all three strains (Fig.3.5b).
The proportion of macrophages showed an initial fall following
infection with all three Corby strains and remained lower than normal in
guinea pigs infected with CV but in animals given CA and CAC the
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Fig.3.5. Changes in alveolar cell populations following infection with
virulent and avirulent, forms of Corby over 30 hours, based on differential
white cell counts.
a. PMNs as a percentage of total population;
b. eosinophils as a percentage of total population;
c. macrophages as a percentage of total population .
• - Corby virulent (CV), • - Corby avirulent, MHIH-derived (CA),
.& -Corby avirulent, BCYE-derived (CAC).
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percentage rose back to normal levels. Fig.3.6 is a graph of PMNLs as a
percentage of the combined PMNL and macrophage populations and
demonstrates the marked increase in these cells in the CV infected animals
compared to little change in the CA and CAC infected animals (apart from
an initial peak at 4 hours). Fig 3.7 demonstrates that the increase in the
PMNL population resulted in an increase in the total numbers of cells in the
lungs in CV infected animals.
3.3.5. INFECTIVITY OF VIRULENT AND AVIRULENT CORBY
STRAINS IN VIVO
Bacterial, viable counts performed on whole, macerated lungs taken at each
time interval from the three groups of guinea pigs are shown in Fig.3.8. Up
to 12 hours post infection CV did not increase in numbers then rapid
multiplication occurred such that at 30 hours COWltSwere 100 fold greater
than at 0 hours. Both CA and CAC counts declined gradually over 30
hours. Fig.3.9 is a graph of the bacterial numbers in whole lung lavage
which were similar to those counted in whole lung macerates apart from
some slight differences such as a decrease in CV up to 8 hours and a
slight rise of CA from 0-8 hours. Numbers of intra- and extracellular
bacteria were also calculated and are given in Fig.3.10. The bacteria in the
CV-infected lungs remained mostly intracellular. CAC was predominantly
intracellular up to around 18 hours then switched to being mainly
extracellular. Apart from the first 4 hours following infection more viable
CA were found within cells than extracellularly and the difference
between the counts became greater with time.
The differences in viable counts of intra- and extra-cellular CA and
CAe from 0 hours to each time point are shown in Fig 3.11. The
predominance of intracellular CA is again clear from this graph.
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There was very little change in the relative numbers of intra and
extracellular CAC from 0-30 hours but the rate at which the viability of this
strain decreased was similar to CA and greater than was apparent from
Fig.3.10.
3.3.6. HISTOLOGY
A subjective score of the numbers of eosinophils in the lungs following
infection was made by veterinary histopathologist Dr. G. Hall and is shown
in Table 3.2. This analysis was performed in order to check the results
obtained by stained smear cell counts.
Table 3.2. Numbers of eosinophils in Haematoxylin and eosin stained
sections of lungs of guinea pigs following aerosol infection of virulent and
avirulent Co br >y.
Subjective score of number
Time (hours) VIRULENT AVIRULENT
0 + +
4 + +++
12 +++ ++
24 ++ +
30 ++ +
3.3.7 FLOW CYTOMETRY
The results obtained by flow cytometry were difficult to analyse due to low
numbers of cells in several samples (which prevented comparisons of
successive and duplicate tests), the similarity of the macrophages and
PMNLs in terms of size and granularity and the high non-specific binding
of antibodies to these cells. Thus a complete study of the progression of
changes in the cell populations was not possible but the histograms shown
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in Figs 3.12-3.18 show that labelling of macrophages and PMNLs was
possible in some samples.
Fig 3.12 is the data obtained when a 0 hour sample was incubated with a
negative control antibody and anti-human HLA-DR antibody (for labelling
macrophages). The top histograms show the total number of 'events' (i.e.
cells and particulate material) recorded and distributed in terms of their
size (forward scatter, FS) and granularity (side scatter, SS). The
distribution was very diverse and it can be seen that a large proportion of
the events were in area 1 which was found to be debris. Through trial and
error the area encircled by the bit-map was found to be the most likely
position to find events carrying the specific FITC label. This can be seen
on the lower histograms which register the percentage of events within the
bitmap which were labelled. The problem most often encountered with this
technique is illustrated in FigJ.13, that of inconsistency between samples
from the two guinea pigs at each time point. In this case the macrophage
population bit-map set at 0 hours located labelled cells in one sample but
not the other. Fig 3.14 is the data from a 12 hour CV infected sample and
shows a change in the distribution of events in the top histogram. The
'sausage'-shaped area contained a greater number of events and was later
shown to be PMNLs (unfortunately the granulocyte label did not work at
this stage). There was also a shift in the macrophage population which
resulted in the movement of the bit-map in the direction of increased side-
scatter which indicated an increase in the granularity of the cells. The data
shown in Figs 3.15-3.17 are of CV-infected lung lavages from a separate
experiment. In an attempt to simultaneously label the cell types the FS and
SS scales were altered to try and differentiate the overlapping macrophage
and PMNL populations. Fig 3.15 confirms that events in the 'sausage'-
shaped area did carry the granulocyte antibody label. Fig 3.16 shows how
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Fig.3.12. Flow cytometric analysis of guinea pig lung lavage immediately
following infection with CV (0 hours). The histograms on the left are a
negative control for the sample incubated with anti-HLA-DR antibody
(FITC-linked) on the right. Histograms 1 and 2 show the distribution of
particles in the sample in terms of size and granularity. Histograms 3 and 4
show the percentages of particles within the circular bit-map which
fluoresce. Thus 33.7% of particles fluoresced following incubation with
anti-HLA-DR compared with 1.9% in the control.
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Fig.3.13. Flow cytometric analysis of guinea pig lung lavage taken 4 hours
post-infection with CV. Histograms as for Fig.3.12 except both are
samples from duplicate animals incubated with anti-HLA-DR showing the
problem of differences in the cells between samples. The control sample
gave a background fluorescence of 1.70/0.
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Fig.3.14. Flow cytometric analysis oflung lavage taken from a guinea pig
12 hours following infection with CV. Histograms as Fig.3.12 but with an
altered bit-map to accommodate movement of the macrophage (HLA-DR
positive) population.
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Fig.3.iS. Flow cytometric analysis of lung lavage of a guinea pig 24 hours
post-infection with CV. The histograms on the left are a control for the
sample shown on the right which had been incubated with an anti-
granulocyte antibody. 35.7% of cells within the elongated bit-map bound
the label compared with 3.3% in the control.
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Fig.3.16. Flow cytometric analysis of a guinea pig lung lavage taken 24
hours post-infection with CV. The sample was incubated with anti-HLA-
DR antibody. Histogram 1 shows the location of three bit-maps used to
identify the macrophage population. Histogram 2 shows fluorescence in
bit-map 1 (red), histogram 3 the fluorescence in bit-map 2 (green) and
histogram 4 the fluorescence in bitmap 3 (orange). The highest percentage
labelling was in bit-map 2 at 21.3% compared with 1.9% in the control (not
shown).
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Fig.3.17. Flow cytometric analysis of guinea pig lung lavage 24 hours post
infection with CV. The sample is the same as in Fig.3.16 but incubated
with an anti-granulocyte antibody. Bit-map 3 in histogram 1 has been
moved to locate the PMNL population seen in FigJ .15. Labelling was
greatest in bitmap 3 (orange), 53.4% compared with the control 1.80/0 (not
shown).
94
the macrophage population was located by using three bit-maps and comparing
the degree of lILA-DR labelling in each. The area within bitmap 2 contained
the largest percentage of labelled cells but Fig 3.17 shows that this area also
contained cells which carried the granulocyte label. Labelling of the cells with
an anti L.pneumophila LPS antibody is shown in Fig.3.18 and it can be seen
that the majority of the label was associated with macrophages although 25%
of the events in the PMNL population contained LPS label.
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Fig.3.18. Flow cytometric analysis of lung lavage 24 hours post-infection
with CV. The sample and histograms as Fig.3.17 but incubated with anti-
L.pneumophila LPS antibody. The greatest percentage of labelling was in
bit-map 2 where the majority of the macrophage population was located.
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3.4. DISCUSSION
Studies aimed at elucidating the pathogenic and virulence mechanisms of
micro-organisms are most frequently performed in vitro where
experimental conditions can be carefully controlled without the
interference of unknown factors. However there is always a risk in such
studies that the laboratory conditions do not successfully mimic those
pertaining in vivo. Ideally the organism should be examined in the
environment appropriate to that which it encounters during disease in its
natural host. In the case of LD this environment is the alveolus and its
associated cell population and the experiments reported herein were
designed to discover interactions of virulent and avirulent strains of
L.pneumophila with this in vivo environment.
Initially the effect of the in vivo environment on the bacteria was studied
I,
by comparing the surface proteins expressed by legionellae grown on
artificial media with those expressed by legionellae multiplying in vivo.
L.pneumophila which had been isolated from macrophages during
experimental infection were found to express fewer proteins than cells
cultured on media when the two were compared by SDS-PAGE and
Western blotting. There was also a reduction in the number of protein bands
which were recognised by antisera raised against legionellae growing in
vivo. This suggests that the large numbers of proteins expressed by
L.pneumophila during artificial culture are not required for intracellular
growth. It was not possible to determine, using these methods, whether any
of the protein bands on blots of the in vivo grown bacteria were unique to
the in vivo environment. The bands could represent novel proteins expressed
in vivo which cross react with antibodies against in vitro grown
L.pneumophila or it is possible that such proteins are present on artificially
cultured bacteria, but greater expression is induced in vivo.
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There were distinct changes of staining pattern between media-grown and
in vivo grown bacteria which merit further comment. A band with molecular
weight of approx. 19 kDa was observed which stained only when blots had
been incubated with anti-in vivo grown Stafford virulent strain. This could
represent antibodies raised against the 19 kDa peptidoglycan-associated
lipoprotein (Engleberg et al., 1984 & 1991) which is known consistently to
elicit a humoral response in guinea pigs (Engleberg, 1993). Interpretation of
the Stafford strain blots was limited because there was no possibility of
unique in vivo induced antigens being seen. Such blots were available for
the Corby strain and although no bands unique to these bacteria were
identified, the staining was limited to a 19kDa band which could be the
antigen described above and to the region of the 36-45 kDa markers.
Putative virulence proteins have been described with molecular weights in
this region namely legiolysin (39kDa, Wintermeyer et al., 1991) which has
haemolytic activity, and zinc metalloprotease or tissue destructive protease
which has a molecular weight of 38kDa and has many possible pathogenic
activities. There was an obvious lack of reaction on in vivo Corby blots in
the 29-24kDa region where two of the most widely reported virulence
factors (MOMP and mip) should be. It cannot be concluded from these
limited experiments that those proteins are not expressed in vivo but it is
worth noting that the majority of the studies involving the MOMP and mip
were performed on BCYE grown L.pneumophila.
An interesting result with this experiment was a 24kDa band which was
observed only on virulent Stafford strain blots, further investigation may yet
prove this to be a virulence associated protein.
Analysis of the proteins produced by in vivo-grown bacteria through
interpretation of Western blots has certain limitations since there may have
been proteins present which were not detected by any of the antisera, either
because the specific antibodies were not present or because the process of
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immunoblotting destroyed the antigenicity of the proteins. Thus, the Western
blot analyses shown in Figs. 3.3 & 3.4, demonstrate that the majority of the
antibodies raised against in vitro grown bacteria did not react with in vivo
grown cells, but do not rule out production of novel antigens which were
not detectable. It should also be noted that the greater number of protein
bands stained with rabbit anti-whole bacteria could be due to non-specific
staining of proteins or peptides bound to LPS. This was described in
Chapter 2 where an anti-LPS monoclonal antibody appeared to immunolabel
protein bands and can be seen in Fig 3.4., lanes 13 and 14 where an anti-
LPS antibody produced a similar staining pattern to the rabbit antisera
(lanes 1-4).
Given these limitations in the technique a clear difference in the proteins
expressed during growth in the in vivo and in vitro environments was
demonstrated.
Similar changes in protein expression were described by Abu-Kwaik et
al., (1993) who found that L.pneumophila in the presence of a
macrophage-like cell line (U937) lost expression of proteins produced on
culture media and expressed several novel proteins. That study employed
the method of two dimensional electrophoresis which distinguishes
proteins by means of their isoelectric potential as well as molecular
weight and achieves abetter separation of protein moieties. The use of a
cell line also facilitated those studies in providing greater quantities of
intracellular bacteria. Providing that sufficient quantities of in vivo grown
legionellae could be obtained with guinea pig cells this could be a more
successful technique with which to study these proteins and the stimuli
which induce them. There is evidence that many pathogens have the
ability to adapt to different environments showing the ability of such
organisms to sense changes around them. This is particularly important
for pathogens which require exploitation of more than one host. As
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mentioned previously Legionella species are found widely in water
environmentsyet only a minority of the strains and species cause human
disease. It is possible that those found exclusively in the natural
environment do not have the regulatorymechanisms to enable the changes
in protein expression which allow adaptation to the conditions found in
vivo. There is also a school of thought that pathogenic legionellae are those
which have exploited and multiplied within species of protozoa
(Rowbotham, 1986). Similarities between the intracellular behaviour of
legionellae within amoebae and macrophages have been shown (Fields,
1993) and it is possible that the ability to synthesise certain proteins could
be important. A study by Barker et al., (1993) described differences in
surface structures and properties of L.pneumophila grown in amoebae and
it remains to be seen whether any similarities exist between these and
macrophage-grown legionellae. Further investigations of in vivo induced
proteins would aid the understanding of the virulence mechanisms of LD
and possibly provide a further insight into the potential pathogenicity of
strains in natural environments.
The experiments described in this chapter were also designed to
determine the interaction of L.pneumophila with alveolar phagocytes in
vivo. The early response of guinea pig alveolar phagocytes to airborne
infection with virulent and avirulent forms of the Corby strain was
compared.
The avirulent strains did not evoke a strong cellular response in the guinea
pigs, the cell populations varied little over 30 hours in terms of quantity
and type of cell. Macrophages were the dominant cell over most of the
experiment but there was no increase in number compared with uninfected
animals. Such cellular inactivity suggests that the innate non-immune
defence mechanismswere able to deal with the invadingbacteria without the
elaboration of complex cellular Immune mechanisms which are often
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described for defence against virulent L.pneumophila. Viability of both
avirulent strains decreased gradually in the lungs but within the time-
course of the experiment they were not completely eliminated. The CAC
avirulent form, also decreased in viability with time in the in vitro assay
described in Chapter 1. The behaviour of CA differed between the in vitro
assay and following challengeof guineapigs. Viabilitywas retained in the in
vitro assay but not in vivo. An explanation could be the efficiency of killing
by macrophages where CAC was effectively controlled by the phagocytes
but CA was less susceptible. This could be seen when the intra- and
extracellular viability of the strains were compared The predominance of
viable CAC changed from being intracellular to extracellular suggesting
that intracellular defence mechanisms were effective but over most of the
experiment there were more viable CA within cells than without. The
decrease in overall viability of CA in guinea pigs would probably have been
mediated by both macrophages and PMNLs. An in vivo study of an avirulent
strain of L.pneumophila Philadelphia 1 (NCTC 11192) found the
organism to be predominantly extracellular with intracellular bacteria
distributed equally between macrophages and PMNLs (Jepras et al.,
1985). This suggests that macrophages and PMNLs do not support the
growth of avirulent strains in vivo. Thus, results obtained in the in vitro
macrophage assay, although indicative of virulence do not necessarily
mirror the situation in vivo.
The Corby virulent strain induced a marked inflammatory response as
demonstrated by, an increase in PMNLs which corresponded with a
decrease inviability in the early stages of infection. This may reinforce the
fact that virulent L.pneumophila strains are susceptible to killing by
these cells. However, since high levels of PMNLs were maintained, the
eventual continued multiplication of CV suggests that any inhibition by
PMNLs was overcome. Protection within macrophages may have been a
101
factor since CV was located predominantly intracellularly but the large
numbers of viable extracellular bacteria suggests that there was an
inhibition of PMNLs in some way. Rechnitzer & Kharazmi (1992) have
shown that L.pneumophila protease inhibited PMNL chemotaxis and this
will be investigated and discussed further in the following chapter. Clearly
the recruitment to the lung of these cells was not affected but it is possible
that a more local action of the protease prevented the PMNLs from
efficiently phagocytosing the bacteria. Resistance to the killing mechanisms
of the PMNLs is another possibility since L.pneumophila has been shown to
produce substances which can inhibit the toxic oxidative responses of these
cells. These are the protease mentioned above (Sahney et al., 1993) and a
low molecular weight toxin (Friedman et al., 1982, Lochner et al., 1985).
Phagocytosis of the virulent Corby in this study was shown by the fact that
25% of the cells in the PMNL population were labelled for LPS (Fig.1S) but
whether this represented viable or killed bacteria was not determined. Jepras
et al., (1985) found, using the same virulent strain in a similar study that, at
24 hours post-infection, 10% of the total viable bacteria were located within
PMNLs. To conclude, a proposal of the role of PMNLs in control of
infection with L.pneumophila would be that even though virulent strains are
susceptible to killing by these cells and do not replicate within them, the
production of enzymes and toxins by the bacteria multiplying within
macrophages reduces the toxicity of PMNLs. Thus, m the
absence/deficiency of PMNLs for example in disease, the virulence of
L.pneumophila is increased and enhancement of PMNL function has proven
effective inthe control of human LD (Hollander et al., 1991).
Further analysis of the eosinophil population was performed since these cells
can be confused with PMNLs on stained cell smears. Histopathological
examination of the lungs of guinea pigs infected with virulent and avirulent
strains revealed that there were changes in the numbers of these cells over
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the course of this experiment. There was little difference in the numbers
between virulent and avirulent infected lungs. The involvement of
eosinophils in the pathology of LD has not been previously noted and since
the Pathologist who examined the sections described their distribution as
being mainly peribronchial it is probable that direct interaction of
eosinophils with legionellae in the alveoli is not a feature of the disease.
These findings do, however illustrate the importance of in-situ examination
of events occurring in vivo.
These results agree in general with those of Jepras et al (1985) in their
comparison of the Corby (virulent) strain with the Philadelphia I (avirulent)
strain although some differences exist. In the current studies the peak of
PMNL influx occurred 16 hours before the peak reported by Jepras et al.
This could be explained by the higher initial dose of Corby in the present
study which was approximately 100 fold more than that of Jepras et al. The
avirulent strain used in that study persisted in guinea pig lungs 14 days
following aerosol challenge. The differences between that strain and the
avirulent strains in these experiments show that conversion of strains by
multiple passage on artificial media is not a straightforward, one component
process and this results in subtle differences in the responses of the host to
challenge with different avirulent strains. Such variations could be partially
responsible for the lack of clear evidence concerning the virulence
mechanisms of LD due to the number of different strains of L.pneumophila
which have been studied.
The analysis by flow cytometry of the variations in cell populations yielded
little more information than microscopy and bacteriology due to the various
difficulties described in the results section. The problems could have been
partially overcome by more extensive testing of reagents and familiarisation
of the cell distributions using uninfected lavages. To compensate for the
variation in the numbers of cells obtained from animals and the alterations in
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cell size and granularity over the course of the disease would require more
guinea pigs per time point. The overlap of the cell populations with each
other and the wide spread of the macrophage populations as seen by the low
percentages of events labelled in each bit-map (maximum obtained was 50%
labelling of granulocytes) was probably the limiting factor to the success of
these experiments. Flow cytometIy is most successful in well defined cell
populations where variations in the quantity and types of cells can be
reliably compared. The use of flow cytometry to examine the responses of
phagocytic cells to legionellae and other bacteria Bass et al (1983) has been
proven with cells cultured in vitro but such studies were beyond the scope
of this investigation which sought to examine events occurring in vivo. The
reactivity of monoclonal antibodies specific for human and mouse
lymphocyte markers with guinea pig cells was an interesting finding which
indicated a similarity of these molecules within mammalian species.
In summary the work described in this chapter has demonstrated that
L.pneumophila growing within guinea pig macrophages exhibits differing
surface proteins to legionellae grown on artificial culture media and that the
host (guinea pig) response to virulent and avirulent bacteria differs from that
seen with macrophages isolated in tissue culture. The conclusion therefore is
that whilst in vitro studies serve a purpose to identify potential virulence
factors the relevance of these to the disease being studied must be confirmed
by examination of the organism within the environment of the natural
disease.
This philosophy is continued in the next Chapter which investigates the
role of a pathogenic factor to which has been attributed many disease-
causing properties but has received conflicting reports concerning its
importance in the disease as a whole.
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CHAPTER4
Tissue destructive protease of Legionella pneumophila
4.1. INTRODUCTION
The main source of energy for Legionella species is provided by
extracellular proteases which are required for cleavage of proteins and
peptides to amino acids . Not long after the first descriptions of the
pathology of LD, proteases, along with extracellular toxins became the
prime candidates to explain the pulmonary and extra pulmonary
lesions. Following the discovery that several human proteins were
degraded by Lpneumophila (Muller, 1980), interest in proteases grew
and large number of extracellular enzyme activities have since been
described (Muller, 1980 & 1981; Thompson et al., 1981; Berdal &
Fossum, 1982;Berdal et al., 1982;Baine et al., 1985; Conlan et al., 1986;
Gul'nik et al., 1986;Rdest et al., 1991). Conlan et al., (1986) showed that
of six discrete protease activities purified from L.pneumophila broth
culture supernatants, only one caused necrosis in the skin of guinea pigs.
This tissue destructive protease (TDP) was a zinc metalloprotease which
has since been studied by a number of workers ( Dreyfus & Iglewski,
1986, Quinn & Tompkins, 1989,Blander & Horwitz, 1989). This enzyme,
has been shown to be at least partially responsible for the pulmonary
damage seen in experimental LD in guinea pigs. When purified TDP was
instilled intranasally in guinea pigs it produced lesions pathologically
similar to those seen in human and experimental LD (Baskerville et
al., 1986). Quantities of TDP sufficient to cause such lesions were
detected in vivo by an ELISA technique in lung homogenates of
L.pneumophila infected guinea pigs (Conlan et al., 1988a) and were
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localised in the lung tissue closely associated with the bacteria and
pulmonary damage (Williams et al., 1987).
TDP acts on a variety of protein substrates (Conlan et al., 1986) and has
been shown to degrade human serum proteins (Muller, 1980 & 1983),
inactivate human a-I-antitrypsin (Conlan et al., 1988b) and inhibit
human neutrophil chemotaxis (Rechnitzer & Kharazmi, 1992). Cytotoxic
activities of L.pneumophila have been attributed to this protease and
genetic studies have confirmed this enzyme to be responsible for the
cytolysis of CHO cells and haemolysis in vitro (Quinn & Tompkins,
1989; Keen & Hoffinan, 1989).
Pseudomonas aeruginosa and Serratia marcescens secrete extracellular
proteases which have similar properties to TDP. The enzymes are known
to be virulence and pathogenicity factors for certain diseases caused by
these bacteria (Holder & Haidaris, 1979; Woods et al., 1982; Lyerly &
Kreger, 1983). Action on a number of substrates by these enzymes is
involved, one example of which is the inactivation of immunoglobulins
IgG and 19A (Holder & Wheeler, 1984; Molla et al., 1986; Heck et al.,
1990). Degradation of human IgG, IgA and IgM by legionellae grown in
the presence of serum has been demonstrated by Muller (1983) but the
effects of purified Legionella enzymes on immunoglobulins are unknown
and were investigated.
A protease with the same properties as TDP has been purified from
L.pneumophila Philadelphia 1 strain and named major secretory protein
(MSP). MSP is believed to have a role in cell-mediated and protective
immunity to experimental LD indicated by lymphocyte proliferation
(Breiman et al., 1987; Blander & Horwitz, 1989). However, Conlan
(1987) found that immunisation with TDP did not protect guinea pigs
from lethal challenge with the CV, despite giving rise to high titre
antibodies. In support of the latter study, Rechnitzer & Kharazmi, (1992)
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demonstrated that Lpneumophila TDP may repress the host response by
inhibition of neutrophil chemotaxis and of the ability of monocytes to kill
intracellular Listeria.
Pseudomonas elastase and alkaline protease have been implicated in
modulation of cellular immunity in a number of ways including
inhibition of PMNL function (Kharazmi et al., 1986) and chemotaxis
(Kharazmi et al., 1984), and inhibition of natural killer cells (pederson
et al., 1987) . The enzymes are known to inactivate cytokines such as
gamma interferon (IFN 'Y) (Horvat et al., 1989) and interleukins (IL)
(Theander et al., 1988), suggesting a mechanism for the inhibition of
immune cell function. It is possible that the inhibitory effects of
L.pneumophila protease described by Rechnitzer & Kharazmi (1992)
were also mediated via cleavage of cytokines. The effect of TDP on
IFN 'Y and IL2 was determined in the present study.
Natural lung defences include protease inhibitors which protect against
damage by endogenous proteases. A high molecular weight
glycoprotein, alpha-2-macroglobulin (a2M) has been shown to inhibit
most endopeptidases non-specifically (Barrett, 1973). This is a major
plasma protein but is also synthesised and secreted by cultured peripheral
blood monocytes (Hovi et al., 1979), fibroblasts (Mosher & Wing, 1976),
embryonic lung cells (Mosher et al., 1977) and human alveolar
macrophages (White, 1980). The latter studies suggested a role for the
inhibitor in defence of the lung against potentially harmful proteases. This
mechanism could also be involved in protection against proteases
produced by bacteria which cause bronchopneumonia's. Inactivation of
TDP bya2M in vivo could possibly protect the host against such lung
damage. Serratia marcescens and Pseudomonas aeruginosa proteases
are able to inactivate a2M thereby evading a potential host defence
mechanism (Molla et al., 1986~ Horvat et al., 1989). The following
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studies were designed to investigate the interaction of TDP with a2M
and determine the implications of this for LD pathogenesis.
The significance of the in vitro observations of TDP activity depends on
demonstration of the enzyme being produced in vivo. The in vivo
production of protease has been demonstrated and quantified by an
ELISA in the lungs of guinea pigs with experimental LD in quantities
sufficient to cause some of the effects seen in vitro (Conlan et al., 1988a).
Production of the enzyme by L.pneumophila multiplying intracellularly
has not been directly demonstrated. Assays based on intracellular growth
of L.pneumophila within guinea pig macrophages were used in this study
to investigate protease production. However, immunological detection of
TDP in vivo does not prove that the enzyme is capable of the activities
described above. To determine whether the enzyme detected in vivo was
functional, protease was purified from infected guinea pig lung washouts
and tested for enzymatic function.
Szeto & Shuman (1990) have described a transposon mutant of
L.pneumophila which was defective in secretion of the major secretory
protein. Blander et al (1990) found that aerosols of this mutant were as
lethal for guinea pigs as the MSP-producing parent strain. This would
appear to conflict with studies in which numerous pathogenic properties
have been attributed to the protease In this chapter, the mutant and its
parent strain were compared with the Corby strain in terms of protease
production and in the guinea pig model in an attempt to explain this
anomaly.
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4.2. MATERIALS AND METHODS
4.2.l. TDP PURIFICATION
TDP was purified from broth (YEB) culture supernatants of
L.pneumophila Corby virulent strain as described by Conlan et al.
(1987).
4.2.2. Alpha-2-MACROGLOBULIN PURIFICATION
A preparation of a2M was first obtained from a commercial source
(Boeringer) but this showed little inhibitory capacity which then rapidly
diminished, so the inhibitor was purified from human plasma by the
method of Barrett (1981). Briefly, human plasma was obtained from a
healthy adult volunteer. Lipoproteins were removed by polyethylene
glycol 6000 (pEG) precipitation, the remaining proteins precipitated
out by PEG and separated by Sepharose 6B gel filtration with
phosphate buffered saline (PBS) pH 7.4 as eluent at a flow rate of 20
ml hour-I. Fractions containing a2M were identified by SDS-PAGE and
a specific inhibition assay described below.
4.2.3. EFFECT OF TDP ON IFNy and IL-2
Purified TOP at concentrations similar to those detected in vivo (20J.1g
ml-I, Conlan et al., 1988a) was incubated with purified human IFNy and
IL-2 (natural and recombinant, Sigma) at 370 C for various times and the
reaction mixtures analysed by SDS-PAGE using Excel gels were
stained with Coomassie blue, as described in Chapter 2. Controls of IFN
y and IL-2 incubated with buffer were included.
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4.2.4. EFFECT OF TDP ON IgG AND JgA
Purified TDP at 72 ug ml-l was incubated with 100 ug ml-1 human IgG
and JgA (Sigma) for 5 hours at 370C and the reaction mixtures
analysed by SDS-PAGE as above.
The effect of TDP on the Fe- and antigen-binding regions of IgG and
IgA was determined using Enzyme-linked immunosorbent assays which
were dependent on the binding of the immunoglobulins in one or other of
these regions. The assays for human JgA were those described by
Ashworth et of (1982) and involved estimates of total 19A (Fe bound)
and of 19A with a specificity for Bordetella pertussis antigens. A rabbit
assay of IgG specific for L.pneumophila LPS was that described by
Conlan and Ashworth (1986)
4.2.5. ASSAY OF INHIBITION OF THERMOL YSIN BY a2M
This assay was used to estimate the capacity of a2M to inhibit the
activity of thermolysin as described by Barrett (1981). Thennolysin
activity was measured spectrophotometrically as the absorbance due to
the release of dye from either Azocoll or Hide powder azure protein
substrates (Sigma). Percentage inhibition of thermolysin bya2M was
calculated by comparing the residual thennolysin activity following
incubation with a2M with the activity of thermolysin incubated without
inhibitor.
4.2.6. INHIBITION OF TDP BY a2M
The inhibition of TDP by a2M was determined in a similar assay to that
described above because TDP also releases dye from Azocoll. A standard
amount of TDP (1Jig) was incubated with various, increasing quantities
of a2M. After an incubation period of 10 min at 370C the activity of TDP
was measured. The percentage inhibition of TDP by a2M was calculated
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by comparing this activity with that of TDP in a control where inhibitor
was replaced by buffer (Tris HCI pH 7.2). Incubation with Azocoll was
for 30min at 370C after which absorbance was read on a Titretek
Multiscan plate reader at 492nm.
4.2.7. PROLONGED INCUBATION OF TDP WITH a2M
To investigate changes in TDP activity on prolonged incubation with a,
2M the protease was reacted with the inhibitor at a molar ratio such that
TDP had a residual activity of approximately 10% of the TDP-only
control. Incubation was continued for various lengths of time up to 28
hours. After each time substrate was added and the residual activity of
TDP determined.
4.2.8. DEGRADATION OF a,2M BY TDP
The TDP inhibition assay described above was used to determine the
molar ratio at which TDP was completely inhibited by a,2M . At this molar
ratio, mixtures of inhibitor and protease were incubated for various lengths
of time then examined by one of the following procedures:
I. Analysis by SDS-PAGE
Samples of a,2M which had been incubated with buffer, TDP, or
thennolysin for 0, 0.5, 1 and 1.5 hours were separated in horizontal, linear
5% acrylamide gels as described in Chapter 1.
2. Thermolysin inhibition assay
Following incubation with TDP or buffer a quantity of thennolysin was
added to the mixture and incubation continued for 10 min after which free
thennolysin activity was measured with hide powder as substrate.
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4.2.9. PROTECTION STUDIES
To investigate the possibility of a therapeutic role for a2M in
Legionnaires' disease guinea pigs treated with purified a2M were
chal1enged with an aerosol of Lpneumophila. In two separate
experiments two groups of 6 female Dunkin-Hartley guinea pigs weighing
300-350g were exposed to L.pneumophila Corby strain as described in
Chapter 2. Both groups were given a 5LD50 dose. In experiment A, one
group was given a single intraperitoneal injection of 40mg human a2M
6h post infection and in experiment B, two intraperitoneal injections of 40
mg each were given 4 and 24 hours post infection. In both experiments
control groups were given PBS in place of the a2M.
The animals were observed for sickness and temperatures were taken
throughout the course of the illness.
Serum levels of a2M following intraperitoneal treatments of an
uninfected guinea pig were quantified by a commercial immunodiffusion
assay (Behring), consisting of agar plates into which defined
quantities of antibodies to a2M were incorporated.
4.2.10. IMMUNOCHEMICAL DETECTION OF TDP
TDP was detected by an antigen capture ELISA based on rabbit anti TDP
IgG raised against purified TDP. The specificity of this antibody and the
ELISA has been determined and described previously (Conlan et al.,
1988a).
4.2.11. INTRACELLULAR PRODUCTION OF TDP IN ALVEOLAR
MACROPHAGES
Guinea pig alveolar macrophages were maintained in tissue culture and
infected with L.pneumophila strains as described in Chapter 2 and
incubated for 24 hours. Enumeration of bacteria by viable counts was
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performed in culture supernatants and macrophage Iysates immediately
following removal of extracellular bacteria and after 24 hours
incubation using the methods described in Chapter 2. These samples were
also assayed for TOP using the ELISA.
4.2.12. IMMUNOGOLD LABELLING OF TDP
Guinea pig alveolar macrophages which had been incubated with
L.pneumophila for 24 hours were harvested and processed for
transmission electron microscopy as described by Williams et al.,
(1987). Ultrathin sections of infected cells were immunogold labelled
using an indirect method (Williams et al., 1987) with rabbit anti-protease
or rabbit anti-LPS as primary antibodies followed by goat anti-rabbit IgG
gold (10nM, Biocell).
4.2.13. IN VIVO ACTIVITY OF TDP
Guinea pigs were given a lethal aerosolised dose of L.pneumophila as
described in Chapter 2. After 3 days their lungs were washed out post
mortem and cells were disrupted by sonication. Cell debris and
bacteria were removed and the supernatant equilibrated in 25 mM Tris-
HC} pH 7.0 and applied to a FPLC Mono Q anion exchange column
(pharmacia) equilibrated with the same buffer. Proteins were eluted off the
column with a O-O.SM NaCI gradient at a flow rate of 1 ml min-1 and
fractions were assayed for TDP by ELISA. Fractions containing IDP
were pooled and concentrated by pressure dialysis over a low protein
absorption ultrafiltration membrane (Amicon) with a molecular weight cut
off of 10000. The concentrate was assayed by ELISA, then added to
wells in an agar plate containing 1% sodium caseinate. The plate was
incubated at 370C for several hours and examined for precipitation of the
casem.
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4.2.14. COMPARISON OF PROTEASES FROM PHILADELPHIA 1
AND CORBY STRAINS
The non-protease producing mutant strain of Philadelphia 1 (2102) and its
parent (2029) were a generous gift from Dr. H. Shuman, New York.
These strains were grown in YEB and the bacteria-free supernatants
were concentrated by pressure dialysis, assayed for TDP activity by
ELISA and casein precipitation and compared with TDP purified from CV.
4.2.15. GROWTH OF STRAINS 2102 AND 2029 IN GUINEA PIG
MACROPHAGES
The mutant and parent strains were tested in the intracellular growth assay
as described in Chapter 2.
4.2.16. VIRULENCE OF STRAINS 2102 AND 2029
The two strains were plated on BCYE agar and suspensions of the
growth made in distilled water. These suspensions were aerosolised and
administered to guinea pigs as described in Chapter 2. An LD50
experiment was performed and, in a separate experiment to monitor
progress of the infection, infected guinea pig lungs were removed
immediately after challenge and at daily intervals thereafter for viable
counts, TOP assay and histopathology.
4.2.17. EFFECT OF CULTURE SUPERNATANT ON GUINEA PIGS
Concentrated broth culture supernatants of 2102 and 2029 were
instilled intranasally into guinea pigs as described by Conlan et al (1987).
The animals were observed for signs of illness and lungs examined
macroscopically and by histopathological techniques
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4.3. RESULTS
4.3.1. EFFECT OF TDP ON IFNy
The result of incubating 24 ug ml-1 TDP for 5 hours with various
quantities of human, natural and recombinant IFNy is shown in Fig.4.1.
This quantity of enzyme degraded recombinant JFNy completely but did
not appear to degrade the natural form. Fig.4.2 shows that degradation of
the recombinant JFNy by only 12 ug TDP ml-l occurred after 4 hours
incubation.
4.3.2. EFFECT OF TDP ON IL2
Incubation of IL2 with TDP resulted In the appearance of a minor
protein band on the gels but did not appear to alter the dominant protein
(Fig.4.3)
4.3.3. EFFECT OF TDP ON IgG AND IgA
No degradation of either immunoglobulin following incubation with TDP
was apparent by SDS-PAGE (Fig.4.4a) however the ELISA results in
Fig.4.4b demonstrate that the enzyme affects the ability of rabbit anti-LPS
IgG to bind to its specific antigen in an ELISA. Incubation with TDP had
no effect on the human 19A in an ELISA measuring total IgA which is
indicative ofFc binding and no difference was seen in the ability of human
IgA to bind to Bordetella pertussis antigens following TDP treatment.
4.3.4. INHIBITION OF TDP BY a2M
TDP activity was inhibited by a 2M in a concentration dependent manner.
Fig.4.5 shows percentage inhibition of TOP by various quantities of a
2M. The activity of 1ug of enzyme was completely inhibited by 14Jlg of
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Fig.4.1 Effect of 5 hours incubation with 24Jlg TDP or buffer on IFNy .
A. Human natural IFNy
1, 1 x 104 U IFNy + TDP; 4, 1 x 104 U IFNy + buffer;
2, 2 x 103 U IFNy + TDP; 5, 2 x 103 U IFNy + buffer;
3, 200 U IFNy + TDP; 6, 200 U IFNy + buffer.
B. Human recombinant IFNy .1-6 as above but IFNy at 2 x 105 U, 4 x 104
U and 4 x 103 U respectively.
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Fig.4.2 Effect of incubation of 12 and 24 ug TDP with 4 x 104 U
recombinant IFNy for various lengths of time.
1, IFNy + 24 ug TDP, 6 hours;
2, IFNy + 12 ug TDP, 6 hours;
3, IFNy + buffer, 6 hours;
4, IFNy + 24 ug TDP, 4 hours;
5, IFNy + 12 ug TDP, 4 hours;
6, IFNy + 24 ug TDP, 2 hours;
7, IFNy + 12 ug TDP, 2 hours;
8, IFNy + 24 ug TDP, 1 hour;
9, IFNy + 12 ug TDP, 1 hour;
10, IFNy + buffer, 1 hour.
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Fig.4.3. Effect of incubating human, natural (n) and recombinant (r) Il2
with TDP.
1, IL2r + 72 ug TDP;
2, IL2r + 24 ug TDP;
3, IL2r + buffer;
4, IL2n + 72 ug TDP;
5, IL2n + 24 ug TDP;
6, !L2n + buffer.
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Total Ig A Specific Ig A Specific Ig G
Fig.4.4 Effect of incubating TDP with purified immunoglobulins.
A. SDS PAGE of human IgG and IgA following incubation for 5 hours with
24 ug ml-1TDP.
1, IgG + buffer; 2, JgG + TDP; 3, IgA + buffer; 4, IgA + TDP.
B. ELISA titre of immunoglobulins before and after incubation with TDP
or buffer in assays measuring total immunoglobulin (Fe binding) or antigen-
specific immunoglobulin. Note that specific IgA and IgG not tested with
TDP at 6 and 12 ug.
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Fig.4.5. Inhibition of TDP activity on azocoll following incubation with
various, increasing quantities of a2M. 100% inhibition occurred at a
molar ratio of a2M:TDP of 1 : 1.3.
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inhibitor, an enzyme:inhibitor molar ratio of approximately 1:1.3. TOP
activity was partially inhibited by as little as 2Jlg of a2M.
4.3.5. REGENERATION OF TOP ACTIVITY
Fig. 4.6 shows the percentage TOP activity remaining after incubation for
various lengths of time from 0 to 28 hours with a quantity of a2M
estimated to give 10% residual TOP activity. Two sets of data are
shown one of which demonstrates that after 28 hours incubation TOP
activity did not significantly increase.
4.3.6. DEGRADATION OF a2M BY TOP
The effect of TDP on the ability of a2M to inhibit thermolysin
following incubation for various lengths of time is shown in Fig.4.7.
When incubated with buffer for 4 hours at 370 C a2M inhibited
thermolysin activity by 100% but when incubated with IDP for the same
length of time the thennolysin inhibitory capacity of a2M was reduced to
approximately 90%. This may be accounted for by the occupation of
binding sites by the TDP which would block the subsequent binding (and
therefore inhibition) of thennolysin. Fig.4.8 shows the results of SDS-
PAGE on the reaction mixtures. Incubation with TDP resulted in a change
of the a2M from a predominantly single band of around 180kDa to
several bands lower than 100kDa although some material remained at
180kDa (lane 5). Incubation with thennolysin caused a similar, but
more complete, alteration of the a,2M with none of the 180kDa band
remaining (lane 6).
121
100
Serratia protease
~ 80
> _--- -I !--O--_-~-----_-_
_0-
..,--__
..,....0'""..,..../.......
0"""
...
U
III
Q. 60
c
I-
Cl
c:'c 40
til
E
Gla::
'of?- 20
•
•--------~1--------'2--------~3~'--------T4--------~5--~1___;8
Incubation time (hours)
Fig.4.6. Inhibition of TDP activity against Azocoll following prolonged
incubation with a2M at a molar ratio of 1 : 1.8 to look for
regeneration of residual activity.
• a2M+TDP, .. a2M+TDP,
protease (from MolJa et aI, 1986).
o Serratia marcescens
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Fig.4.7. Effect of incubation with TDP on the capacity of a2M to inhibit
thennolysin activity against Azocoll.
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Fig.4.8. SDS-PAGE of reaction mixtures of a2M incubated with TDP
and thennolysin. Lanes:
1. TDP only;
2. thennolysin only;
3. a2M + TDP 0 hours;
4. a2M + buffer 4 hours;
5. a2M + TDP 4 hours;
6. a2M + thennolysin 4 hours.
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4.3.7. PROTECTION STUDIES
Tables 4.1 and 4.2 show temperatures and survival times of guinea pigs
challenged with a lethal aerosol of L.pneumophila after injection of a2M
or PBS. In experiment A (Table 4.1), four of the control group died on
day 2 and all were dead by day 3, an average survival time of 2.2 days,
calculated, by dividing the total number of days the animals survived by the
total number of animals which died (Fitzgeorge et al., 1986). In the a.2M
treated group there was one death on day 2, 4 died on day 3 and one
animal survived to day 5, an average survival time of3.8 days.
In experiment B (Table 4.2), three of the PBS control group had died by
day 3 and all were dead by day 4, an average survival time of 3.4 days.
The a2M treated group were all alive on day 3, two died on day 4 and all
were dead by day 5, an average survival time of 4.6 days.
Serum levels of a2M in an unchallenged guinea pig given the same doses
of inhibitor as the animals in experiment B (Table 4.2) reached a
maximum of 1.4 mg ml-1 over the course of the experiment (Fig.4.9). No
a2M was detected in a lung lavage of an unchallenged animal 4 days
following similar i.p. injections and these treated animals showed no
clinical signs of illness.
4.3.8. INTRACELLULAR PRODUCTION OF TDP
The results of the guinea pig macrophage assay are shown in Table 4.3.
Bacterial counts in macrophage lysates increased 100-1000 fold from 0-
24 hours. Washing procedures following infection of monolayers resulted
in few or no extracellular bacteria at 0 hour but after 24 hours quantities
of CV in the supernatants were similar to those in the lysates. Since
the culture media did not support the growth of this strain multiplication
must have occurred intracellularly.
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Fig.4.9. Quantities of a,2M in the serum of a normal guinea pig given
intraperitoneal injections of inhibitor in parallel with guinea pigs challenged
with L.pneumophila. Arrows indicate time of administration at 4 and 24h
post infection ..
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Table 4.3. Production of TDP by L.pneumophila in guinea pig
macrophages in tissue culture. Values for TDP are the means of
duplicate ELISA tests, the range shown in brackets. The results of four
experiments are shown.
SUPERNATANT INTRACELLULAR
Time viable concentration viable concentration
(hours) legionellae of protease legionellae of protease
c.fu. / ml (Jlg / 106 c.f u.) c.fu. / ml (Jlg / 106 c.fu.)
0 a. 0 ND 2.4-2.5 x 103 ND
b. NT NT 2.4-2.7 x 105 ND
c. NT NT 2.2-3.6 x 105 ND
-
4.l-7.1 x 103d. NT NT ND
24 a. NT NT NT NT
b. 8.3-9.1 x 106 0.074 5.0-6.9 x 106 0.221
(0.071-0.078) (0.21-0.232)
c. 0.4-8.0 x 107 0.146 l.1-1.6 x 107 0.106
(0.022-0.27) (0.051-0.l62)
d. l.5xl06 0.267 l.1-2.3 x 106 0.133
(0.085-0.182)
ND= not detected. NT= not tested.
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Tissue culture medium and lysing agent had no effect on the ELISA and
no protease was detected in bacterial suspensions incubated with cell-
free culture medium nor at 0 hours. After 24 hours incubation,
approximately 0.1-0.2fJ.g TDP/l 06 bacteria was detected in culture
supernatants and celllysates. Table 4.4 shows the comparison of CV with
CA and CAC. No multiplication of the avirulent strains occurred between
o and 24 hours and no TDP was detected by ELISA.
4.3.9. IMMUNOGOLD LABELLING OF TDP
Figure 4.10 a and b show a cell containing numerous bacteria with gold
particles marking the presence of TDP which was distributed
throughout the phagosome and the cell cytoplasm. Few particles were seen
due to the small quantities of enzyme being present in each cell. Fig 4.IOc
is a cell section incubated with control IgG in place of primary antibody
as a negative control and shows no specific labelling.
4.3.10. IN VIVO ACTIVITY OF TDP
The results of the ELISA for TDP on fractions of infected guinea pig lung
lavage lysate which eluted off the Mono Q column are shown in Fig 4.11.
The maximum reaction with anti-TDP antibody occurred at a salt
concentration of 0.36-0.4SM. which was the same as those fractions
which caused casein precipitation when broth culture supernatant was
separated under equivalent conditions (indicated by shaded area). The
TDP-containing fractions were concentrated and applied to a casein agar
plate. The resulting precipitation is shown in Fig.4.12., well 1. No
precipitation of casein by the elution buffer was seen (well 2) and purified
TDP showed strong precipitation (we1l3).
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Table 4.4. Intracellular production of TDP by Corby virulent and
avirulent strains in guinea pig macrophages incubated for 24 hours.
o hours 24 hours
Intracellular Intrace 11ular TDP by ELISA TDP/106 c.f.u
bacteria bacteria (ug) (ug)
(c.f.u./m1) (c.f.u.lml)
CV 2.4-2.7 x 105 5.0-6.9 x 106 1.33 0.221
CA 1.3-2.9 x 105 5.0-6.l x 105 ND -
CAC 2.8-3.0 x 104 5.8-6.6 x 103 ND -
ND= not detected
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AB
Fig.4.10. Immunogold labelling for TDP in gumea pig alveolar
macrophages infected in vitro with L.pneumophila.
A, 100 nm section of a macrophage incubated with affinity-purified anti-
TDP JgG (x9,600)
B, as A but magnification x 29,000.
132
cC, macrophage section incubated with control JgG (x 29,000).
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Fig.4.11. Anion exchange chromatography of infected guinea pig lung
lavage supernatant using FPLC. Elution of proteins by a salt gradient is
shown by absorbance at 280nm. Fractions were assayed for TDP by ELISA
and the absorbance at 450nm due to the substrate colour reaction is shown.
- A280~ ------ A450~ -- NaCI gradient.
0- Fractions of broth culture supernatant which caused greatest
precipitation of casein following separation under equivalent conditions.
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Fig.4.12. Casein precipitauon assay of infected lung lavage fractions
which gave a positive reaction in the TDP ELISA.
Row I, doubling dilutions of pooled, concentrated ELISA +ve fractions;
Well 2, buffer control;
Well 3, purified TDP (55J.lg/ml)
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4.3.11. COMPARISON OF PROTEASES FROM STRAINS 2029 AND
CORBY
Culture supernatant from Philadelphia 1 strain 2029 precipitated casem
(Fig. 4.13, well 4) and reacted in the ELISA (data not shown). The
zone of precipitation caused by strain 2029 was larger than that produced
by CV but, as the numbers of viable bacteria in the broth cultures were not
estimated, production of IDP by these strains was not compared
quantitatively Concentrated culture supernatant of the mutant strain 2102
also precipitated casein though to a much lesser degree (Fig.4.13, well 3)
indicating that the mutant produced IDP in broth culture.
4.3.12. INTRACELLULAR MULTIPLICATION OF STRAINS 2102
AND 2029
Strains 2102 and 2029 multiplied within gumea pig macrophages in
vitro at the same rate as each other and a similar rate to CV (Fig.4.14).
4.3.13. VIRULENCE OF STRAINS 2102 AND 2029
Table 4.S shows the results of challenging guinea pigs with aerosols of
2029 and 2102 in comparison with CV. The LDSO of2029 and 2102 were
similar to each other but much greater than that for CV. Guinea pigs
given the parent and mutant strains survived longer than Corby infected
animals even though the latter received a much lower challenge dose.
There was no significant difference between the parent and mutant strain
in the LD 50 experiment.
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Fig.4.13. Casein precipitation assay of broth culture supernatants of
L.pneumophila 2029 (parent) and 2102 (mutant) strains in comparison
with Corby.
1, Broth control;
2, Unconcentrated supernatant of 2102;
3, Supernatant of 2102 concentrated xl 00 showing faint precipitation;
4, Supernatant of2029 concentrated xIOO;
5, Supernatant of Corby concentrated xIOO;
6, Purified Corby TDP.
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Fig.4.14. Intracellular multiplication of strains 2029, 2102 and Corby within
guinea pig alveolar macrophages in cell culture .
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Table 4.5. LD50 of 2029 and 2102 for guinea pigs infected by the aerosol
route and survival rates of guinea pigs following challenge in
comparison with CV.
LD50 Average survival time
(days)
2029 105.3 4.5
2102 105.6 4.7
CV 102.3 3.0
Bacterial counts and TDP production are shown in Figs.4.15. and 4.16.
Data for CV is that Conlan et al (1988). Multiplication of CV occurred
rapidly increasing from 5.7 to 9.3 10glOcolony forming units / lung in 2
days. The parent (2029) and (2102) mutant strain multiplied at a much
slower rate taking 5 days to achieve similar counts (Fig.4.15). No
protease was detected in any of the lung macerates from 2102 infected
guinea pigs. Protease was detected after 2 days infection with 2029 and
levels increased at a similar though much delayed rate than that produced
by CV (Fig 4.16). Protease production by 2029 and CV was at a
maximum at the time of death.
Histopathological examination of sections of lung infected with 2029 and
2102 revealed similar pathology though the lesions were fewer and less
extensive in the mutant infected lungs than the parent (Fig.4.17)
4.3.14. EFFECT OF CULTURE SUPERNATANT ON GUINEA PIGS
The lungs of guinea pigs treated with concentrated broth culture
supernatants of parent and mutant strains are shown in Fig.4.18. The
parent strain supernatant induced visible haemorrhage (4 .18a) which was
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Fig.4.15. Viable L.pneumophi/a in, macerated lungs of guinea pigs infected
with strains 2029 and 2102 in comparison with Corby .
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Fig.4.16. Quantities ofTDP in macerated lungs of guinea pigs infected
with strains 2029 or Corby. • -CV, .. - 2029.
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AB
Fig.4.17. Haemotoxylin and eosin (H+E) stained sections of guinea pig
lungs following infection with strains 2029 and 2102. Magnification x500.
A. 2 days post infection with 2029;
B. 2 days post infection with 2102;
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cD
c. 4 days post infection with 2029;
D. 4 days post infection with 2102.
In each case lesions were less extensive in the 2102 infected lungs than
2029 infected lungs
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AB
Fig.18. Effects of concentrated culture supernatants of strains 2029 and
2102 when instil1ed intranasally into guinea pigs.
A. 2029 treated whole lung;
B. 2102 treated whole lung;
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cD
C, section of lung treated with 2029, H+E stain, x500;
D, section of lung treated with 2102, H+E stain, x500.
Lungs given 2029 supernatants were more severely damaged than 2012
treated lungs both macroscopica11y and on examination of tissue sections.
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confirmed by histopathology as an acute inflammatory reaction involving
extensive tissue damage and cellular infiltration (4.18c). The mutant
strain concentrate did not appear to damage the lungs externally (4.18b)
though an inflammatory reaction was found to have occurred on
examination of lung tissue sections (4. 18d).
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4.4. DISCUSSION
The pathology of infection by L.pneumophila is well characterised as an
acute bronchopneumonia involving alveolar tissue oedema which
consists of a protein rich fluid containing fibrin and numerous
polymorphonuclear leukocytes (PMN) and macrophages. The mechanism
by which these lesions are formed has been attributed to the tissue
destructive protease which produces identical lesions when
administered in a purified form to guinea pigs. Many of the activities of the
purified enzyme which have been described in in vitro studies also support
the hypothesis that TDP is responsible for the lung damage. The
experiments reported in this study explore and substantiate a role for TDP in
LD pathogenesis.
The in vitro experiments in this investigation showed that quantities of
TDP, equivalent to those detected in vivo in aerosol infected guinea pigs,
degraded or inactivated proteins of possible significance to the host in
protection against infection with L.pneumophila. Gamma interferon (IFNy)
has been shown to inhibit replication of L.pneumophila in alveolar
macrophages in vitro (Nash et al., 1988). Concentrations of human
recombinant IFNy well above those which caused inhibition in the latter
study were completely degraded by TOP as shown by SDS-PAGE in this
study. Natural IFNy did not appear to be degraded though this may be due
to "quenching" of the protease by serum albumin in which the IFNy was
provided. In a guinea pig intraperitoneal infection model of LD, T-cell
proliferation was linked to production of a macrophage activation factor
which inhibited intracellular proliferation and had the properties of IFNy
(Nikaido et ai, 1989). In the guinea pig model of LD used in these studies,
virulent strains of L.pneumophila multiplyrapidly and unabated throughout
the course of disease, suggesting that newly recruited macrophages are as
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susceptible to the bacteria as those in the initial stages of disease. If TOP
does inactivate IFNy in vivo, up-regulation of macrophages could be
inhibited, providing a means by which TOP facilitates further proliferation
of bacteria intracellularly.
Degradation of Interleukin2 (IL2) by TDP was not clearly shown in
these SDS-PAGE studies and only a minor protein band was affected.
Pseudomonas proteases inhibit proliferation of lymphocytes through
cleavage of IL2 which cannot then bind to receptors on the lymphocytes
(Theander et al., 1988). It is possible that even a minor alteration in the
configuration of the IL2 molecule would interfere with receptor binding
but this would have to be proved with an assay of IL2 function following
incubation with TOP. Cleavage of IL2 by TOP could interfere with
macrophage activation by preventing IL2-mediated T-cell proliferation.
Degradation of immunoglobulins G and A was not apparent by SDS-PAGE
studies, though inhibition of specific binding of purified IgG following
incubation with the enzyme was demonstrated. IgA binding was not affected,
though the saturation of TOP by other proteins in the sample tested cannot
be ruled out. The role of immunoglobulins in protection against LD is
regarded as being insignificant compared with that of cellular immunity. A
humoral antibody response does occur, directed largely at the serogroup
antigen but vaccination-induced antibody does not protect against
experimental infection with L.pneumophila (Baskerville et al., 1983b) The
bacteria are resistant to serum killing in the presence of antibody and
complement (Horwitz & Silverstein, 1981) but the role, if any, of IgA in the
lungs has yet to be investigated. A large number and variety of proteins
are found in lungs and, since the relative affinities of TDP for any of these
substrates is unknown, in vitro observations made with purified substances
should be treated with caution.
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The importance of a microbial pathogenic or virulence factor can be
demonstrated by showing moderation of the effects caused by that factor by an
inhibitor. In this investigation TDP was completely inhibited by the
protease inhibitor alpha 2 macroglobulin (a2M) in vitro. Protease activity
was abolished at enzyme:inhibitor ratios similar to those measured for other
proteases inhibited by a2M (Molla et al., 1986). The inhibition appeared to
be irreversible with no regeneration of TDP activity on prolonged incubation
such as that seen with Serratia marcescens protease (Molla et al., 1986,
Maeda et al., 1987). Incubation with TDP for up to 4 hours reduced the
inhibitory capacity of a2M but this could be accounted for by the
occupancy of binding sites on the inhibitor by TDP. Feldman et al., (1985)
have shown that a2M has two binding sites, therefore after incubation of a
2M and TDP at a molar ratio of 1:0.9 a reduced number of binding sites were
available on the inhibitor. Thus the decrease in inhibitory capacity of a2M
shown in Fig.4.7 was not due to degradation by TDP.
There is a discrepancy between these findings and those of Muller (1983)
who described degradation of a2M by L.pneumophila strains grown in the
presence of serum. Since that study was not on purified protease it is
possible that the activity was due to another protease. However, Muller used
changes in electrophoretic mobility as an indication of degradation. Barrett
(1979) described an increase in electrophoretic mobility of a2M following
binding of proteinases (or amines) due to a conformational change from the
"slow" to "fast" form of the molecule. Similar changes in the protein bands on
SDS-PAGE gels to those described by Barrett were seen in this study
following incubation with TOP or thermolysin (Fig.4.8).
Protection against the lethal effects of Pseudomonas aeruginosa
proteases by a2M has been shown in a burned mouse model to be due to
inhibition of one of the bacterium's' enzymes (Holder and Haidaris, 1979).
There was some evidence in this study that a2M protected guinea pigs from
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infection when the animals were treated with the inhibitor after challenge
with a lethal aerosol of L.pneumophila (Table 4.1). Although treatment did not
prevent death the animals' survival was prolonged by 1.6 days (experiment A)
and 1.2 days (experiment B). Since a2M has a molecular weight greater than
700kDa it is possibly not surprising that no a2M was found in a lung
washout of a treated, uninfected animal. However as a result of the vascular
damage seen in this experimental LD model (Baskerville et aI., 1983), more
a2M may have been present in the treated, infected animals. It is also possible
that levels of a2M in the lungs were not sufficient to inhibit all the TOP
produced. Administration of a2M by aerosol inhalation rather than
intraperitoneal injection may result in greater protection. The increased
survival of a2M treated guinea pigs is unlikely to be due to protection
against damage by PMN enzymes since it has been demonstrated that little
if any contribution to the lung damage in LD is made by these enzymes (
Fitzgeorge et al ,1988). The host response to invading organisms in the lung
is a complex array of non-specifically induced substances which include
proteases and their inhibitors. The effects of introducing a non-specific
protease inhibitor such as a2M are difficult to predict in such an environment
since inhibition of host as well as bacterial proteases may occur.
However, given the evidence that TDP has the potential to mediate many of
the pathogenic effects of LD it is possible that the prolonged survival was
due to a moderation of these effects by a2M.
The intracellular production of TOP within gumea prg alveolar
macrophages was .confirmed in this study by ELISA and immunogold
labelling of infected macrophages. Quantities produced in the
macrophages were less than those detected in guinea pig lungs but given
the difference in viable count between infected lungs and this assay (i.e. 100
fold greater in lungs) the amount of TOP produced in the assay could be
extrapolated to that found in whole macerated lung. Macrophages are
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considered to be the principal site of replication of L.pneumophila in the
lungs so it is likely that local concentrations of TOP are even higher.
TOP was not produced by avirulent fOnDS of the Corby strain within
guinea pig macrophages. Conlan (1987) found that CAe produced TOP
when grown inYEB and this study (Chapter 2) showed that, when growth in
the culture medium was comparable, there were no differences between the
virulent and avirulent pairs in the production of TOP nor any other enzyme
activities. However, in vivo where the avirulent strains did not multiply,
production of the tissue destructive protease either did not occur or was
below the detection limits of the ELISA. Thus the avirulent strains have the
ability to produce TOP but, in vivo, multiplication is required in order to
produce sufficient quantities of the enzyme. Since some of the activities of
TOP involve inhibition of anti-microbial strategies (Rechnitzer & Kharazmi,
1992, Sahney et al., 1993) it is possible that, without TOP, avirulent strains
could be cleared from the lungs more readily than virulent ones.
The use of an immunological assay does not confirm that the enzyme
detected in vivo is active . In this study functional activity of TOP purified
from lungs of guinea pigs with experimental LO was demonstrated by
caseinase activity of material which reacted in the ELISA for TOP. Thus it
was shown that L.pneumophila produces large quantities of a highly active
and tissue destructive enzyme in vivo which is supportive of an important
role for TOP in the pathogenesis ofLD.
Comparisons of the protease (MSP) produced by the Philadelphia 1
strain, which was used to prepare a protease-minus mutant, with that
produced by CV, demonstrated that the two enzymes were
immunologically and biochemically similar. When given to guinea pigs as a
fine particle aerosol both parent and mutant bacteria had very low
virulence. In order to cause disease, very large doses of the organism had to
be administered and the guinea pigs took several days to die (Table 4.4).
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However parent and mutant forms had similar LDso values and TOP was
detected in vivo by ELISA of lung macerates from animals infected with the
parent strain but not in those infected with the mutant. This confirmed that
production of protease was not required for death of guinea pigs. There was
a distinct difference in the progression of disease caused by the
Philadelphia strains compared to Corby, suggesting an inherent
difference in the pathogenesis of the three strains. Histopathological
evidence has indicated that the degree of severity of alveolar necrosis
varies considerably in different outbreaks and is characteristic of the
disease-causing strain of L.pneumophila (Baskerville, 1988). Where such
variations occur anyone pathogenic / virulence factor may be more or
less critical in causing morbidity or mortality. In the case of the
parent/mutant strains alternative disease-causing factors could be another
enzyme or a toxin. Examination of the lungs infected by the parent
strain, and following administration of culture supernatant, revealed
lesions typical of LD in the guinea pig (Baskerville, personal
communication and Figs 4.17 a & c, 4.18c) which were either caused by the
protease or a substance with similar activity. Such lesions were also found
in the lungs of guinea pigs infected with the mutant strain (and in those
given culture supernatant) but were less extensive than those caused by
the parent strain (Figs 4.17b & d, 4.18d). In their original description of
these strains Szeto & Shuman (1989) reported that the mutant exhibited
a residual casein precipitating activity approximately 1000 fold less than
the parent strain and this was also demonstrated here (Fig.4.l3). If low
levels (undetectable by ELISA) of protease were produced by the mutant in
vivo it is possible that the lung lesions were caused by TDP and it cannot be
concluded that the strain causes death independently of protease production.
Since the levels of protease were below the detection limits of the ELISA it
is likely that other factors contributed to the lung damage seen following
152
infection with the mutant. Given the 'leaky' nature of the mutant strain
and the low virulence of it and its parent strain, the evidence based on these
strains does not exclude a role for TDP in the pathogenesis ofLD.
The enzyme may not be the single factor which determines the outcome of
disease in the Philadelphia 1 strain of L.pneumophila but the experiments
reported in this Chapter have added to the existing evidence of a
pathogenic role for TOP by demonstrating more potential host-modulating
activities and proving intracellular production and in vivo activity. It seems
likely that TOP is one of a number of virulence factors which contribute to
the pathogenesis of Legionnaires' disease.
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CHAPTERS
An immunocompromised mouse model of Legionnaires' disease
5.1. INTRODUCTION
Investigations of the pathogenesis of most infectious diseases are greatly
aided by an animal model which exhibits the same characteristics as
the disease in humans. Such a model not only allows elucidation of the
pathogenic mechanisms but is vital in evaluation of therapeutic measures to
control or eradicate the disease.
A variety of animal systems have been used to assess virulence and
pathogenesis of L.pneumophila which include embryonated hens eggs
(McDade & Shephard, 1979), and various cultured cells such as epithelial
cells (Daisy et al., 1981), alveolar macrophages from various animal
species (Kishimoto et al., 1979; Fitzgeorge, 1985; Rechnitzer et al.,
1992) ,blood monocytes (Horwitz & Silverstein, 1981) macrophage-like
cell lines (pearlman et al., 1988) and free living protozoa (Rowbotham,
1980; Fields et al., 1986.)
Apart from marmosets, Rhesus and vervet monkeys (Baskerville et al.,
1983) the only whole animal model to successfully mimic the disease of
humans is the guinea pig. However many of the guinea pig models used
involve infection via the peritoneum or trachea which Fitzgeorge et al.
(1983) showed to be inappropriate routes in determining virulence of
L.pneumophila strains. The aerosol infection model used throughout the
studies in this thesis induces a pneumonia in guinea pigs typical of that seen
in humans and has been used extensively to study virulence pathogenesis
diagnosis and treatment of LD (Baskerville, 1988). There are, however,
limitations to the use of guinea pigs not least of which is that these animals
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do not have an immune deficiency, a factor usually predisposing humans to
Legionnaires' disease (LD)
The severely compromised immune deficient (SCID) mouse has a genetic
defect under the control of a recessive (scid) gene which results in
deficiency of immune functions mediated by T and B lymphocytes (Bosma
et al., 1983). These animals are highly susceptible to opportunistic
infections and have been used as models of human diseases which affect
immunocompromised individuals (Mead et al., 1991). Since the main risk
groups for LD are immune deficient, the SCID mouse may be a suitable
model for this disease when an aerosol route of infection is used. The SCID
mice used in this study were a variety (beige, bg) bearing not only the
SCID mutation but additional defects in natural killer (NK) cells and
possibly other granulocytes. Granulocytes have been shown to limit the
spread of L.pneumophila infections (Fitzgeorge et al., 1988) and NK. cells
have a possible role in defence (Blanchard et al., 1988) indicating that the
SCID/bg mouse would be susceptible to LD. To investigate this, SCJD/bg
mice were exposed to aerosols of L.pneumophila in comparison with Balbc
mice which do not have an immune deficiency
SCID mice do not have the ability to reject foreign material and are
therefore able to tolerate cells from other species and, since the defect is
mainly in lymphocytes, any foreign lymphoid or stem cell introduced can
become a part of a normal immune system (Bosma et al., 1983).
Introduction of human cells therefore results in a mouse with a partially
human immune system. Models of human disease should ideally involve
species as closely related to man as possible so disease models in
humanised SCID mice have the potential to be extremely useful. The
opportunity to use such mice presented itself through experiments which
were in progress to humanise SCID/bg mice using peripheral blood
leukocytes. The mice were assessed for susceptibility to Lpneumophila
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aerosol infection with the intention of developing a model to investigate
cellular mechanisms operating during infection.
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5.2. MATERIALS AND METHODS
5.2.1. SCID/bgMICE.
The SCID/bg mice used in these experiments, described by McDougall et
al. (1990), were obtained from the University of Guelph, Guelph, Ontario.
They were bred in-house under the supervision of Dr. B.W. McBride who
kindly provided these mice and those which had been reconstituted with
human peripheral blood lymphocytes.
5.2.2. EXPOSURE OFMICE TO AEROSOLS OF L.PNEUMOPHlLA.
Mice were challenged with a lethal aerosol of L.pneumophila, serogroup 1
Corby strain as described in Chapter 1 using the Henderson apparatus
connected to a 3-jet collison spray to generate aerosols from a water
suspension ( 1 x 1010 colony forming units ml-I) of the bacteria and
delivered to the snouts of the mice. The mice were exposed to the aerosol
for exactly 5 minutes after which time 2 mice were killed and their lungs
removed for counts of viable legionellae. At daily intervals mice were
observed for signs of illness and a proportion were killed and their lungs
removed for viable bacterial counts and histopathology. Bacterial viable
counts were performed on macerated half portions of lungs which were
serially diluted in distilled water, 0.2 ml aliquots of dilutions were plated
onto BCYE agar and incubated for 3 days at 370C. The corresponding half
lungs were either fixed in 10%buffered formal saline and processed for wax
embedding or deep frozen prior to cryo-embedding and sectioning. Tissue
sections 5urn thick were stained with haematoxylin and eosin and by
immunocytochemical labelling with antibodies to L.pneumophila LPS (see
Chapter 2) and human lymphocyte surface markers. Histopathological
analysis was performed by Dr. G.A. Hall and immunocytochemicalanalysis
by Dr. B.W. McBride.
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5.2.3. INTRACELLULAR FATE OF L.PNEUMOPHILA IN SCIDIBG
ALVEOLAR MACROPHAGES
The lungs of 8 SCID/bg mice were washed out with tissue culture medium
(MEM containing 5U Heparin ml-1), 4 hours after aerosol challenge with
L.pneumophila. Viable bacterial counts were performed on the lavage fluid
before and after the cells were removed by centrifugation at 200g for 10 min.
A portion of the cell pellet was removed and the cells disrupted by adding 200
J.110.8% (w/v) digitonin and incubating for 10 minutes at 370C. The cell lysate
was diluted in distilled water and plated onto BCYE to determine the number
of viable, intracellular L.pneumophila. The remainder of the cells were
resuspended in MEM containing 5% newborn calf serum and were counted
m a Neubauer haemocytometer. The volume was adjusted to give a
concentration of 1 x 105-106 macrophages ml-I and 200JlI aliquots added to
wells of a 96 well tissue culture plate (Nunc) and allowed to settle at 370C
for 30 min. Non-adherent cells and extracellular bacteria were then washed
away. The final wash was plated onto BCVE to check that all bacteria had
been removed. Viable bacterial counts were performed on the tissue culture
medium and washed, disrupted cells after 48 hours incubation at 370C.
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5.3. RESULTS
5.3.1. CHALLENGE OF SCID/BG MICE WITH CV
Following aerosol administration of 16 SCIDI beige mice with 1 x 1010
viable CV ml-I no signs of illness were observed in any of the animals
and an initial 0 hour bacterial count of around 7 x 105 viable Corby ml-1
was gradually reduced over 9 days (Fig.5.1).
When the SCID/bg and Balbc mice were challenged with CV in parallel
neither strain showed signs of illness and the viable counts of CV in the
lungs showed a similar reduction with time (Fig.5.2).
5.3.2. INTRACELLULAR FATE OF CV IN SCIDIBG MACROPHAGES
Table 5.1 shows that 4 hours following challenge with CV the pooled
lung lavages of 8 mice contained 2.5 x 104 c.f.u. ml-l and the
majority of these bacteria were extracellular. The lavage cells when placed
in tissue culture contained no recoverable intracellular CV but 6.9 x 102
bacteria ml-1 were present in the culture medium. After 48 hours
incubation no viable bacteria were found associated with the cells despite
8 x 103 bacteria I ml being present in the culture medium.
159
6 • •
5
i i
4-e._
•=~3.
C,J
~
~
2
I
o 5 61 2 43 7 8
Fig.5.1. Viable, bacterial counts of L.pneumophila in the lungs of
SCID/beige mice following aerosol challenge.
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Fig.5.2. Viable, bacterial counts of L.pneumophila in the lungs of
SCID/beige and Balbc/c mice following aerosol challenge.
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Table 5.1. Viable counts of intra and extracellular Lpneumophila in
SCID/bg mouse lung lavages after challenge with CV and following
incubation of cells in tissue culture
Viable count (c.fu'/ml)
whole lavage 2.5 x 104
extracellular fraction 2.27.x 104
Viable count (c.fu'/ml)
o hours 48 hours
cells in tissue culture nd nd
culture supernatant 6.96 x 102 8.05 x 103
nd = not detected.
5.3.3. CHALLENGE OF RECONSTITUTED SCIDIBG MICE WITH CV
SCID/bg mice which had been treated with human peripheral
lymphocytes were challenged with a potentially lethal aerosol of CV.
Viable counts of CV in the lungs are shown in Fig 5.3. Multiplication
occurred with viable counts increasing from 105 up to 1010 colony forming
units/ml. These mice also became ill and the arrows indicate animals which
died. There were three deaths in total, two on day 1 and one on day 2.
Some of the mice did not become ill and in this group the numbers of
viable CV decreased with time.
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Fig.S.3. Viable L.pneumophila in the lungs of reconstituted SCID mice
following aerosol challenge. The arrows indicate mice which died. Deaths
were at day 1 and day 2.
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5.3.4. HISTOLOGY OF LUNGS OF RECONSTITUTED SCIDIBG
MICE INFECTED WITH CV.
The analysis of infected lung sections stained with haematoxylin and eosin
as interpreted by histopathologist Dr.G.A. Hall was as follows. Two
distinct types of pathology were seen one of which was characterised by
inflammation and tissue damage and the other by thickening of the alveolar
walls and the presence of large numbers of macrophages.
Immunostaining of tissue sections with anti-L.pneumophila LPS gave a
variable reaction which was related to the numbers of legionellae obtained
by viable counts. Fig.5.4 shows representative results of this labelling in a
section of lung from an animal which had an increase in the numbers of
legionellae compared with 0 hours.
Human macrophages and lymphocytes were not observed in tissue sections
stained with appropriate antibodies.
Table 5.2. summarises the results of immunostaining and histopathology in
relation to viable counts.
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Fig.5.4. Photomicrographs of lungs of SCID/beige mice reconstituted with
human peripheral lymphocytes challenged with L.pneumophila and
immunostained with an antibody against L.pneumophila LPS. The bacterial
antigen is stained brown and the tissue counterstained with haematoxylin.
Magnification, x125.
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T bl 52 S f . bi t d hia e . . ummary 0 VIa e coun s an sto ogy.
Days post Viable COWlt Score of Category
infection minus that at Oh specific according to
(loglO c.f.u.) labelling for CV pathology
1 3.03 nt nt
1 2.56 +++ A
1 2.52 +++ A
2 4.44 nt nt
2 -0.49 +/- C
2 0.03 - C
2 2.11 +++ A
2 2.5 +++ A
3 -1.48 + C
3 -1.17 +/- C
3 1.67 +++ A
3 -1.46 +/- C
4 -1.83 - C
4 -2.58 - C
4* -2.75 +++ C
6 -4.75 - C
6 -4.75 - C
nt = not tested.
Category A = 'Acute' i.e. Inflammation and tissue damage
Category C = 'Chronic' i.e. Thickening of alveoli, macrophages.
* This animal may have had infection in only one lobe of the lung which
was processed for histology and not bacteriology.
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5.4. DISCUSSION
Cell mediated immune responses are widely reported as being the most
important defence mechanisms against invasion by L.pneumophila yet the
results of the present study found that an animal with a defect in its'
immune cells was able to resist infection by the aerosol route. Despite
having a severe immune deficiency the SCID/bg mice were as able to clear a
lethal dose of L.pneumophila from the lungs as the Balbc mice. Neither of
the mouse strains showed any signs of illness. To investigate the resistance
of SCID/bg mice to L.pneumophila infection the intra- and extracellular
environments of the lungs were examined immediately following challenge.
No viable bacteria were recovered intracellularly suggesting that the
SCID/bg macrophages either did not phagocytose the legionellae or that
they were killed very efficiently upon entry to the cell. Whichever is the
case will be determined in future experiments but it is likely that the scm
mice do not succumb to disease following aerosol challenge because the
macrophages do not support the growth of L.pneumophila
The scid mutation affects differentiation of lymphocytes such that no
functional T or B cells mature from stem cells but myeloid cell
differentiation is not affected (Dorshkind et al., 1984). Bancroft et aJ,
(1986) have shown that peritoneal macrophages of SCID mice respond to
Iymphokines in culture, with enhanced expression of la molecules. Such
activation of macrophages was also observed following infection with
Listeria monocytogenes. Thus the non-permissiveness of SCID/bg
macrophages for legionellae was perhaps not surpnsmg but further
demonstrates the requirement for a defect in macrophage defence
mechanisms for L.pneumophila to establish an infection. In the study
mentioned above (Bancroft et al., 1986), SCID mice which were infected
with Listeria were unable to inhibit the spread of infection and unlike
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control mice (without the mutation) developed chronically high loads of
bacteria. The apparent discrepancy is due to the fact that T-cell dependent
responses are critical in the control of infection by this organism and
suggests that this is not the case for L.pneumophila. Most strains of mice are
not susceptible to LD due to an inability of L.pneumophila to multiply
within mouse alveolar macrophages (Yamamoto et al., 1987). Peritoneal
macrophages obtained from an inbred strain of mice (AlI) allowed growth
of L.pneumophila (Yamamoto et al., 1988) but the whole mice were
resistant to intravenous challenge with the bacteria (Yamamoto et al.,
1992) because these mice elicit T-cell responses capable of inhibiting
growth of legionellae. The resistance of All mice to infection with
L.pneumophila demonstrates that, when macrophages do allow replication
of legionellae, lymphocyte function is important in determining susceptibility
or resistance. However, it should be noted that the latter studies involved
peritoneal not alveolar macrophages and the route of infection was
intravenous not by aerosol. As mentioned previously the route of
infection and use of the most appropriate model of the in vivo
environment can be critical in determining the pathogenesis of disease. It
would be interesting to discover the outcome of aerosol infection of All
mice with L.pneumophila and to examine the susceptibility of alveolar
macrophages.
The results reported here clearly demonstrated the importance of the non-
specific, innate defences of the lung since, without any immune cell
involvement, the legionellae were cleared from the lungs as efficiently
as mice with intact immune systems.
SCID/bg mice reconstituted with human peripheral leukocytes
were found to be susceptible to infection with the Corby strain of
L.pneumophila, multiplication occurred with viable counts increasing from
105 up to 1010 colony forming units/ml. These mice also became ill and
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death occurred rapidly in some animals. Some of the mice did not become
ill and in this group the numbers of viable CV decreased with time.
Examination of the lung tissue by histopathological techniques
revealed that the animals in which there was multiplication of CV showed
signs of inflammation and tissue damage. Lung tissue of the mice which
did not support growth of CV was filled with macrophages causing a
thickening of the alveolar walls. Immunostaining for CV correlated to the
bacterial lung counts. A hypothesis to explain these different responses is
that the lungs of the mice which became ill contained a greater proportion
of permissive human macrophageslmonocytes than the mice which cleared
the infection. The pathology in the lungs of the ill mice is consistent with
the release of L.pneumophila pathogenic factors and infiltration with
inflammatory cells. It is possible that only a few permissive macrophages
could initiate the effects seen since L.pneumophila exoproducts, in
particular TDP, have been shown to deplete host defences in numerous
ways (see Chapter 4). The large numbers of macro phages seen in the lungs
of resistant mice would have to be non-permissive mouse macrophages for
this hypothesis to be correct. Immunostaining with human lymphocyte
markers showed that neither human T and B cells nor macrophages were
present in the lung sections. This would appear to confirm that the
macrophages in the resistant group of mice were of mouse origin. The lack
of staining in the mice which allowed growth of CV could be explained by
degradation of these cells by the bacteria or even masking of the surface
antigens by the large quantities of L.pneumophila antigens.
Reconstitution of the mice with peripheral blood lymphocytes
resulted in a promising but inconsistent model of LD but perhaps this was
not the most effective method to model for an infection the pathogenesis of
which is centered around a specialised cell located within the lungs.
However L.pneumophila challenge of the mice following reconstitution
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with isolated populations of human alveolar macrophages in comparison
with macrophages plus human T cells could determine the relative
contributions of these cell types to defence against LD and provide a
consistent, highly relevant model of LD.
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CHAPTER6
Concluding Discussion
6.1. COMPARISON OF VIRULENT AND AVIRULENT
L.PNEUMOPHlLA.
The aims of the studies presented in this thesis were to provide
information which contributed to the understanding of the virulence and
pathogenesis of Legionella pneumophila in an experimental model of
Legionnaires' disease (LD). Examination of virulent and paired avirulent
strains revealed that an ability to multiply within cultured alveolar
macrophages was a characteristic of strains which caused disease in guinea
pigs, yet no factor was clearly identified upon which this ability was
dependent. Similar findings have been reported (Horwitz, 1987) and it
would appear that avirulent forms of L.pneumophila which have been
produced by passage on artificialmedia do not exhibit changes in anyone
of the putative virulence factors described to date. The reason for this
could be either that the factor which the avirulent strains lack has yet to be
discovered or, that several factors are required for virulence of
L.pneumophila and a combination of these are defective in avirulent
strains.
In these studies, avirulent L.pneumophila were phagocytosed by
guinea pig alveolar macrophages, so it is events which occur after this
process which discriminated virulent and avirulent bacteria. Defective
triggering of the oxidative burst of macrophages by virulent legionellae
compared with paired avirulent forms has been reported (Summersgill et
al., 1990) as a reason why virulent and not avirulent strains are able to
multiply intracellularly. A candidate for the inhibition is the mip protein
described in Chapter 2 which has protein kinase C (PKC) inhibitory
activity (Hurley et al., 1993). PKC is believed to be involved in the
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initiation of the oxidative burst by signalling the reduction of oxygen to
superoxide anion by NADPH oxidase (Clark, 1990). Expression of mip by
both CA and CAC was shown in the present studies but, as neither the
quantity nor activity of the protein were determined, it was not possible to
state whether the mip was functional. However, in the macrophage assay,
CA and CAC did not display the same pattern of intracellular viability
which has been described for mutants lacking mip (Cianciotto et al.,
1989b) i.e. inhibition in the early stages, followed by multiplication,
indicating that the avirulent forms had not lost mip activity. The
involvement of mip in the early stages of intracellular replication was thus
not clearly demonstrated in these experiments A possible reason is that the
mip protein does not exert the proposed effect on guinea pig alveolar
macrophages since the suggested role of PKC in the early stages of the
respiratory burst is based on evidence derived from experiments on
PMNLs. Alternatively, another bacterial factor could be involved which
has a more significant effect on the anti-microbial activation of
macrophages than the action of mip. A low molecular weight toxin,
produced by L.pneumophila which, when incubated with PMNLs, inhibits
their subsequent oxidative response to a phagocytosed particle by
preventing membrane depolarization (Lochner et al., 1985) could be such a
factor. The requirement for pre-incubation of PMNLs with the toxin
suggests that it would not be involved in the initial encounter of CV with
macrophages but, as there is no information regarding the effects of the
toxin on macrophages, nor has it been reported whether avirulent strains
produce the toxin in equivalent quantities to virulent strains, the possible
involvement in the early intracellular events is speculative.
A role for TDP in the disruption of phagocyte defences has been
mentioned in Chapter 4 but, like the toxin, the effects reported required
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pre-incubation of PMNLs and monocytes with the enzyme (Rechnitzer &
Kharazmi, 1992).
At present the mip is the only reported protein which seems likely to
have an effect in the early stages of the intracellular survival of
L.pneumophila but its mode of action has yet to be clearly defined and,
given that mutants lacking mip are still able to multiply intracellularly and
that the avirulent strains in the present study expressed the protein it is
probable that other factors are involved. Whatever the cause, the inability
to repress the oxidative burst of macrophages is a plausible reason why
avirulent strains do not multiply within these cells. However the evidence
for this theory is based on experiments performed on monocytes and
PMNLs in vitro and, although there were significant differences between
each virulent and avirulent pair of strains, variations between strains were
such that some avirulent bacteria were more inhibitory than virulent forms
(Swnmersgill et al., 1988 & 1990). It was also shown that, while both
virulent and avirulent legionellae had the ability to inhibit the oxidative
burst, the activation of these cells was not prevented and some toxic
oxygen species were produced. The fact that virulent bacteria are able to
multiply therefore implies a resistance to these metabolites. Differences in
the susceptibilities of virulent and avirulent L.pneumophila to the xanthine-
xanthine-oxidase system (the end products of which are the same as that
produced during the oxidative burst), in particular to hydrogen peroxide
and to a lesser extent superoxide anion, have been shown (Jepras &
Fitzgeorge, 1985). These studies were performed on CV and CAC and it
was found that CV was more resistant to hydrogen peroxide and
superoxide anion than CAC. This resistance was probably due to a greater
production of catalase and superoxide dismutase (respectively) by CV seen
when these activities were measured in broth-grown CV and CAC.
Virulent L.pneumophila, therefore, not only elicit a reduced
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oxidative burst, they are more resistant to the toxic products than avirulent
legionellae. The studies reported by Jepras & Fitzgeorge (1985) also
showed that two avirulent strains of L.pneumophila differed in their
resistance to ki1ling by singlet oxygen, a toxic product of the xanthine
oxidase system. Such differences could explain the killing of CAC by
guinea pig alveolar macrophages compared to the intracellular survival of
CA in the present study.
The levels of catalase and superoxide dismutase produced by
intracellular CV are not known but it is possible that production may be
enhanced on exposure to the toxic oxygen species. Salmonella
Iyphimurium responds to the presence of hydrogen peroxide by
synthesising stress-induced proteins which aid the intracellular survival of
the bacterium. A similar stress-induced system may operate in
L.pneumophila producing proteins such as catalase which protect against
the oxidative attack. It is apparent from these studies and others (Abu-
Kwaik et al., 1993) that L.pneumophila secretes a different combination of
proteins following incubation with macrophages to that produced by
growth on culture medium. Identification of proteins produced only on
exposure to the intracellular environment could reveal more possible
virulence factors. Further information may also be obtained by examining
the oxidative response of alveolar macrophages to virulent/avirulent
L.pneumophila in the early stages of experimental infection. The
simultaneous measurement of phagocytosis and phagocytosis-induced
respiratory burst is possible using fluorescent markers and flow
cytometry. "Bass et al (1983) described a technique which quantifies the
respiratory burst of individual PMNLs as the oxidation (by hydrogen
peroxide) of 2'7'dichlorofluorescein diacetate (DCF-DA) to the highly
fluorescent 2'7'dichlorofluorescein (DCF). Szejda et al., (1984) used this
technique and Texas Red-labelled bacteria to correlate phagocytosis
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with the resulting respiratory burst ofPMNLs. Using this dual fluorescence
technique it may be possible to investigate the oxidative response of
macrophages and PMNLs taken directly from infected guinea pigs
following aerosol challenge with CV, CA and CAC.
Inhibition of phagosome-lysosome fusion has been reported as the
critical property in allowing intracellular replication of a strain of
L.pneumophila compared with its' avirulent counterpart. (Horwitz, 1987)
but this may not always be the case since virulent legionellae are known to
allow fusion and still multiply (this study, Rechnitzer & Blom, 1989).
Thus, while prevention of contact with lysosomal enzymes may be a
virulence mechanism for some legionellae it may be resistance to
lysosomal contents which is important in others. Experiments which
measure the levels and toxicity of lysosomal enzymes released following
incubation with strains of differing virulence are required.
Survival of L.pneumophila within the hostile environment of
macrophages is important but it has been shown here and elsewhere that
survival is not sufficient. Avirulent strains were able to withstand 48 hours
inside macrophages in the in vitro assay yet their inability to multiply
meant that the defences of the guinea pig were sufficient and no disease
resulted. The focus of research should perhaps move towards finding out
how virulent strains are able to grow intracellularly rather than how they
resist killing. It has been suggested that the availability of iron from the
labile iron pool of monocytes is a critical determinant for intracellular
replication by L.pneumophila (Byrd and Horwitz, 1989). Avirulent strains
have been shown to have a greater (4-fold) requirement for iron than their
virulent counterparts for growth in vitro (Johnson et al., 1991) despite the
fact that both use similar ferric reductases to obtain the iron (Poch &
Johnson, 1993). The ferric reductase of avirulent legionellae showed a 2-
fold increased activity when NADPH was used as reductant (compared
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with NADH) and the authors speculated that this may affect utilisation of
iron intracellularly due to the decrease in NADPH during phagocytosis.
There is no evidence to suggest that the legionellae require NADPH from
the intracellular environment of the macrophages and, since the enzymes
were identical in every other respect, the extra requirement for iron by
avirulent strains has not been explained. The quantity of available iron
might therefore distinguish the ability of virulent and avirulent strains to
multiply intracellularly, since the virulent forms are able to utilise smaller
quantities. Thus, regardless of the ability to survive intracellularly, the
virulent strains have the advantage through being able to utilise
intracellular iron.
In summary, there are a number of differences between virulent and
avirulent strains which are related to their ability to cause LD
experimentally. Virulent forms reduce the anti-microbial reactions of
phagocytic cells, are better able to resist the products of the oxidative
response and, utilise intracellular iron more efficiently than their avirulent
counterparts.
Events occurring in the early stages of infection with L.pneumophila
are thus becoming clearer and with improvements in the genetic
manipulation of the organisms and realisation of the need to study bacteria
growing intracellularly the principal factors which control these events
should soon be identified. Inhibition of such factors would certainly
prevent disease and, if a vaccine were warranted for a disease which has a
lower global mortality than many diseases for which there is no vaccine,
one could be developed with this knowledge.
6.2 PATHOLOGY OF LD
The processes occurring following multiplication of L.pneumophila in the
lungs are less well-defined than those discussed in section 6.1., although
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many have been proposed. Given the difficulties in prompt diagnosis of LD
they are equally important, serving to define goals for effective therapy.
The evidence for and against the role of TDP in the disease was discussed
in Chapter 4 but, considering the possible importance of the enzyme,
merits further discussion here. There is a large discrepancy between the
findings of work performed on TDP at this laboratory and that of Blander
et al., 1990. The results of work performed at CAMR have shown that the
enzyme is responsible for the damage to lung tissue which is seen during
LD but the American workers provide evidence which suggests that TDP
is not required for deaths, typical pathology and progression of disease to
occur. This was concluded by the fact that a mutant strain of
L.pneumophila which did not produce the protease was as virulent for
guinea pigs as the parent strain from which it was derived. When these
strains were examined in the guinea pig aerosol infection model in the
present studies differences in the interpretation of results were apparent,
the most striking of which was the fact that both parent and mutant had
been reported to be highly virulent for guinea pigs but very high doses of
the strains were required to cause disease. At these high doses both strains
caused disease and death in guinea pigs but the virulence and progression
of disease was much less severe than strains normally used to cause LD in
this model. There was also a slight difference in the virulence of the strains
in that the LDso and average survival time of the mutant were greater than
the parent. The results of histopathological analysis of lung sections
following infection in the two models showed an important discrepancy. In
the experiments of Blander et al (1990) the authors concluded that the
enzyme could not be responsible for the characteristic pathological lesions
of LD because the mutant strain caused identical lesions to the parent
strain. When compared in the CAMR. model of LD the lesions caused by
the mutant strain were much less severe than those caused by the parent.
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Such reduced necrosis caused by infection with the mutant strain supports
the role of the enzyme in contributing to the pathogenesis of disease. The
mutant is known to produce very small quantities of proteolytically active
TDP which may be responsible for some of the pathology and there was no
mention of this in the Blander et a/ publication. The discrepancies between
the evidence obtained using this mutant in the two laboratories sheds doubt
on the role of TDP in vivo but it is important to consider that the evidence
based on this mutant stands alone in supporting a theory that the enzyme
does not have a significant role in the pathogenesis of LD. There is, on the
other hand much evidence, both direct and circumstantial which supports a
role for TDP. The cytotoxicity of the enzyme has been characterised
genetically and purified TDP is known to cause lesions identical to those
seen during LD. Quantities of proteolytically active enzyme sufficient to
cause such lesions have been detected in vivo in guinea pigs and in human
macrophages. Legione//a micdadei does not produce the enzyme and
causes disease in humans less frequently than L.pneumophi/a and infection
only results in a severe form of illness in immunocompromised individuals.
The properties of the enzyme are such that it degrades substances which
may directly or indirectly contribute to limiting the spread of
L.pneumophila in the lungs and an inhibitor which neutralised the activity
of TDP caused an increase in survival when given to guinea pigs but did
not prevent death. Perhaps the use of animal models which use death as an
end point are too severe a test of the role of the enzyme.
There is little doubt that TDP can cause the lung damage which is
seen during LD but this does not exclude other toxic substances produced
by L.pneumophi/a eliciting similar damage in the absence of TDP. The
TDP-minus mutant examined in the present studies caused a pathology
typical of LD in guinea pigs, but it is probable that, in this instance, other
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factors contributed to the lung damage. These may have been bacterial or
host derived.
There are other substances produced by legionellae in artificial
culture which have disease-causing properties but the role of these during
experimental or human infection has yet to be established. One such
substance is a low molecular weight (3400 kDa), toxin which was first
described by Friedman (1980) and Hedlund (1981) and was shown to
inhibit human neutrophil function (Hedlund, 1981, Friedman et al., 1982
Lochner et al., 1985). The toxin has received little attention since and there
is no evidence that the toxin is produced by L.pneumophila growing in
vivo at the concentrations required to exert the inhibitory effects on
neutrophils. In the initial reports of the toxin the purified form was shown
to have a lethal toxicity for mice and on isolated mouse macrophages
(Hedlund, 1981) but the mechanism of this toxicity was not reported. An
enzyme which has haemolytic activity distinct from that of TDP has been
described (legiolysin, Rdest et al., 1991). It has no proteolytic activity but
could have the same haemolytic activity as TDP and contribute to the lung
damage. Enzymes produced by PMNLs are known to cause pathological
effects in the lungs (Janoff, 1985) but it is thought that these are not an
important cause of lung damage seen in LD because guinea pigs with
induced neutropenia exhibited typical LD pathology following aerosol
challenge with virulent L.pneumophila. Although not a major cause,
PMNL enzymes may still be able to contribute to the lung damage under
normal circumstances. A combined attack by host and bacterial toxins and
enzymes is therefore feasible and may explain why a similar pathology can
occur when one component e.g. TDP is missing. Aside from the tissue
destructive action, there are also several enzyme activities demonstrated
for L.pneumophila which could have the same overall properties of TDP in
the absence of the latter. An example is the acid phosphatase produced by
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L.micdadei which inhibits superoxide anion production (Saha et al., 1985).
L.pneumophila also produces an acid phosphatase (Conlan et al., 1986)
which may have the same properties as that secreted by L.micdadei. The
different activities of TDP which have been proposed as pathogenic
mechanisms of L.pneumophila could therefore possibly be accounted for
by other enzymes/toxins of bacterial or host origin. However, as TDP has
all these properties and is produced in vivo in sufficient quantities to exert
the proposed effects, it is a strong candidate for the principal disease
mediator and it is difficult to ignore the effects which neutralisation of the
enzyme may have on the prognosis of patients with LD.
Enzymes with activities/properties different to those of TDP are also
being discovered. L. micdadei produces protein kinases which may have a
role in modulating anti-microbial processes by phosphorylation of host
proteins (Saba et al., 1988) although no relevant protein substrate has been
identified and similar activity has not been found in L.pneumophila. An
ADP-ribosyltransferase has been detected and purified from lysates of
L.pneumophila and although its precise function has not been identified it
is thought to have a similar activity to exotoxin S, an important virulence
factor of Ps.aeruginosa (Belyi et al., 1991).
Thus, numerous mechanisms by which L.pneumophila prevents the
host from eradicating the infection have been proposed. There is little
doubt that more than one factor is responsible for the pathogenesis of the
disease and understanding the situation as a whole is complicated by the
large number of strains of L.pneumophila which have been studied. This
was portrayed in Chapter 3 by the difference in virulence between the
Corby strain used in these studies and the Philadelphia 1 strain which has
been the basis of much experimentation. It is difficult to compare the
findings of experiments on bacteria which exhibit vast differences in
virulence.
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6.3 ANIMAL MODELS OF LD.
The use of experimental models of infection is also variable and
much of the information regarding virulence has been performed either in
tissue culture of cells which were not alveolar in origin or in animal models
using routes of administration which were inappropriate to the airborne
nature of contraction. The susceptibility of SCID mice which had been
given a human lymphocyte system to infection with L.pneumophila could
result in more definitive investigations where the interaction of the bacteria
with the cells it encounters in human disease can be studied in a whole
animal model.
6.4 ENVIRONMENTAL FACTORS-ROLE OF AMOEBAE
L.pneumophila is a self limiting, opportunistic pathogen, man is its
only natural animal host and there are no means for its persistence in man.
Person to person transmission does not occur and the patient either dies
or eradicates the bacteria. The bacteria can survive very successfully in
low-nutrient water environments and the strategies it must employ to
multiply and be competitive in such an environment, may also be those
which allow it to survive and multiply in the harsh circumstances of the
alveoli. Comparisons between replication of legionellae within amoebae in
water and macrophages in alveoli have often been made and it is tempting
to suppose that mechanisms which allow survival of the killing mechanisms
of amoebae are the same as those which permit survival and replication
within macrophages. There is some evidence to support this assumption
but the processes occurring following uptake of legionellae by amoebae are
only just beginning to be studied at a molecular level. One report has
suggested that the amoeba Acanthamoeba polyphaga exhibits an oxidative
response comparable to that of neutrophils when virulent and avirulent
legionellae are phagocytosed by either cell (Halablab et al., 1990). Since
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mutants defective in the nup protein, are deficient in intracellular
replication in amoebae in a similar manner to that in macrophages
(Cianci otto & Fields, 1992), it is possible that similar events occur in the
early stages of infection of amoebae as in macrophages and that
L.pneumophila employs the same strategy to overcome them in both. It
was mentioned in Chapter 3 that the proteins expressed by L.pneumophila
change following intracellular replication within amoebae and that this also
occurs following infection of macrophages. Since amoebae ingest bacteria
to digest as a food source, resistance of legionellae to the digestive
enzymes would be required and this may be related to resistance to
lysosomal enzymes in macrophages. However Fields (1993) has proposed
that L.pneumophila avoids exposure to lysosomes by multiplying within
the smooth or rough endoplasmic reticulum of the cell, analogous to the
phagosome-lysosome fusion inhibition theory. Further studies are clearly
required and care must be taken to avoid generalisations about a bacterium
which has a complex pathogenesis. It should be remembered that other
species of Legionella, which rarely cause human disease are able to
multiply within amoebae suggesting that intracellular replication within
amoebae is not an indicator of virulence in humans. The route from water
to the respiratory tract is prone to a range of influences and, in order to
cause disease, a combination of factors are important not only in the
environment and in the lungs but also during transmission from one to the
other.
6.5. CONCLUSION.
To conclude, the studies presented in this thesis have confirmed
previous work, supported current work by others and added new
information regarding the nature of L.pneumophila growing in vivo and the
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response of a guinea pig host to virulent and avirulent bacteria. Further
evidence supporting the role of the tissue destructive protease has been
provided and a novel animal model incorporating human cells described.
The virulence and pathogenic mechanisms of L.pneumophila have been
discussed and it is apparent that several bacterial, host and environmental
factors are involved. Avirulent forms of L.pneumophila produced by
multiple passage on artificial media have limited use as tools for
elucidating virulence factors of the organism since the changes which result
in the loss of virulence are multiple and appear to vary depending on the
strain of L.pneumophila used. Genetic manipulation of L.pneumophila has
provided information regarding certain proteins which are a part of the
disease process but genetic techniques will only be of use if performed on
strains which are virulent in relevant models of the disease.
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